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Abstract 
Background 
This thesis comprises three different studies; a prison health staff study from New South 
Wales (NSW); Australia, a Norwegian staff study and an assessment of the Norwegian 
opioid maintenance treatment (OMT) programme. The background for the prison health 
staff study was that some prison health staff in NSW, Australia had discouraged inmates 
from entering or remaining in OMT (1). Thus it was decided to investigate staff attitudes 
among prison health staff. In Norway there were some indications that there were 
differences between regional OMT centres in terms of key staff members attitudes (2). 
Norwegian staff attitudes were therefore assessed using the same instrument as in the prison 
health staff study. The original instrument was cross-culturally adapted from Australian-
English to Norwegian. Since 2004 annual assessments of the Norwegian OMT programme 
had identified treatment differences between the 14 regional OMT centres (2-5). However 
possible patterns between treatment organisation, practices and outcomes had not been 
assessed and described. An assessment of the OMT programme in regards to associations 
between treatment characteristics, practices and outcomes was therefore performed. In 
addition a study from 2007 had identified an association between key Norwegian OMT staff 
members’ attitudes towards OMT and prescription of benzodiazepines (6). It was therefore 
decided to investigate if there was an association between OMT staff attitudes in the 
Norwegian OMT programme and variations in treatment organisation and practices. 
Study aims 
The overall aims of this thesis were to investigate staff attitudes towards and knowledge of 
OMT among treatment providers in different settings in a culturally appropriate manner. It 
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also aimed to cross-culturally adapt an attitudinal instrument from Australian-English to 
Norwegian. It further aimed to explore differences in treatment organisation, clinical 
practices and outcomes within the Norwegian OMT programme and to assess OMT staff 
attitudes and its possible associations with treatment organisation, practices and outcomes.  
Material and method 
The three studies had cross-sectional designs. The prison health staff study was conducted 
in 2003 in NSW, Australia; all health staff employed by Justice Health NSW were invited to 
participate (n=396). The Norwegian attitudinal staff study was undertaken in 2007 among 
140 OMT staff and 180 harm reduction staff in Oslo. The two attitudinal studies used an 
instrument that measured attitudes towards and knowledge of methadone. The instrument 
was cross-culturally adapted in the Norwegian population according to suggested guidelines 
(7-10). The assessment of the Norwegian OMT programme used data from the annual OMT 
assessment November 2007 and 2008. This assessment comprised all OMT centres (n=14) 
and aggregated patient information from all centres. Patient information was based upon 
results from a 53-items questionnaire completed for each patient as part of the annual 
assessment of the Norwegian OMT programme.   
Results 
51% of the prison health staff from NSW, Australia participated. Participating staff were 
more likely to support the principles of abstinence-orientation in methadone treatment 
compared to previously surveyed OMT staff. Staff with more experience in and knowledge 
of methadone were less likely to support abstinence-orientation in methadone treatment. 
All invited Norwegian OMT staff participated and 72% of the invited Norwegian harm 
reduction staff participated in the Norwegian attitudinal study. The cross-cultural adaptation 
process revealed that Norwegian staff were unfamiliar with the principles of abstinence-
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orientation. Instead a new attitudinal scale was identified. Those that were more likely to 
support disciplinary discharge from treatment due to in-treatment drug use and limitations 
on intake criteria were labelled “rehabilitation-oriented”. Norwegian OMT staff were more 
“rehabilitation-oriented” compared to the harm-reduction staff. There was no association 
between measured attitudes and level of knowledge of methadone or experience in the 
addiction field in Norway.   
The assessment of the Norwegian OMT programme found marked variations between 
centres in caseload, choice of agonists, prescribing doctor, as well as in the use of drug 
screening and supervised dispension. Centres in which patients had more drug use had less 
social rehabilitation in terms of long-term living arrangements, unemployment, and social 
security benefits as main income. These differences were associated with each centres’ 
attitudes towards OMT. “Rehabilitation-oriented” centres had smaller caseloads, more 
frequent urine drug screening and increased case management. In addition they had less 
drug use and more social rehabilitation among their patients. 
Discussion 
The cross-cultural adaptation process highlighted the dangers in taking an instrument into 
use in a new setting without adjustments. The attitudes measured among Australian prison 
health staff were not valid among Norwegian staff. Instead an attitudinal scale that 
measured attitudes towards disciplinary discharge due to drug use and limitations on intake 
criteria was identified. The assessment of the Norwegian OMT programme identified 
variations in treatment organisation, practices and outcomes between the regional OMT 
centres. These variations were associated with Norwegian OMT staff attitudes towards 
OMT. These findings suggest that there exist different organisational cultures between the 
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regional OMT centres which include staff attitudes and treatment practices that are likely to 
influence treatment outcomes.  
Conclusion 
This thesis provide baseline information for future follow up studies to measure changes in 
staff attitudes and the associations with treatment organisation, practices and outcomes after 
the introduction of new guidelines and regulations. Additionally the findings from this thesis 
suggest that future OMT programme assessments should include measures of staff attitudes 
towards OMT as it appear to be an important factor in this type of treatment. 
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Norwegian summary 
Bakgrunn 
Denne avhandlingen inneholder tre ulike undersøkelser; 1) en holdningsundersøkelse fra 
fengselsvesenet i New South Wales (NSW), Australia, 2) en norsk holdningsundersøkelse 
og 3) en undersøkelse av det norske LAR-programmet. Bakgrunnen for den australske 
holdningsundersøkelsen var at helsepersonell i fengslene i NSW, Australia advarte innsatte 
fra å begynne eller fortsette med vedlikeholdsbehandling med metadon (1). I Norge hadde 
en evaluering av LAR-programmet i 2004 avdekket behandlingsforskjeller mellom de ulike 
regionale LAR-sentrene. Det var indikasjoner for at ansattes holdninger kunne være en 
medvirkende faktor i disse behandlingsforskjellene (2;6). LAR-ansattes holdninger ble 
undersøkt med samme spørreskjema som ble brukt i den australske holdningsundersøkelsen. 
Mulige mønstre i behandlingsforskjellene mellom LAR-sentrene og samvariasjon mellom 
behandlingspraksis og behandlingsutfall var aldri blitt undersøkt og beskrevet. En slik 
undersøkelse ble derfor gjennomført. 
Formål 
Det overordnede formålet med denne avhandlingen var å undersøke holdninger til og 
kunnskap om LAR blant ansatte i fengselsvesenet i NSW, Australia og LAR-ansatte og 
skadereduksjonsansatte i Norge. Det var også et formål å krysskulturelt tilpasse et 
holdningsskjema fra australsk-engelsk til norsk. I tillegg var det et formål å undersøke om 
det var noen mønster og samvariasjon mellom ulike typer behandlingspraksis og 
behandlingsutfall mellom de ulike LAR-sentrene og hvorvidt ansattes holdninger 
samvarierte med slike behandlingsforskjeller. 
Material og metode 
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De tre inkluderte studiene var tverrsnittsnittsundersøkelser. Den australske holdningsstudien 
ble gjennomført i 2003 blant helsepersonell (n=396) i fengselsvesenet (Justice Health) i 
NSW, Australia. Den norske holdingsundersøkelsen ble gjennomført høsten 2007 blant 
LAR-ansatte (n=140) og ansatte i skadereduksjonstiltak i Oslo (n=180). De to 
holdningsundersøkelsene brukte et instrument som målte holdninger til LAR, samt 
kunnskap om risiko og fordeler ved bruk av metadon. Instrumentet ble krysskulturelt 
tilpasset for bruk i Norge basert på retningslinjer for slike krysskulturelle tilpasninger (7-
10). Undersøkelsen av LAR-programmet inkluderte alle de regionale sentrene (n=14) og 
aggregerte pasientdata fra samtlige sentre. Undersøkelsen brukte data fra den årlige 
statusundersøkelsen høsten 2007 og 2008.  
Resultater 
Halvparten (51%) av alt helsepersonell i fengselsvesenet i NSW, Australia deltok i 
undersøkelsen. De som var mer tilbøyelige til å støtte prinsippet om at metadonbehandling 
kun skulle gis med det hovedformål at pasientene skulle bli rusfrie, uten 
substitusjonsmedisin hadde mindre kunnskap om og mindre tidligere erfaring med 
metadonbehandling. 
I den norske holdningsundersøkelsen deltok alle inviterte LAR-ansatte og 72% av de 
inviterte skadereduksjonsansatte. Gjennom den krysskulturelle tilpasningen fant man at den 
australske holdningsskalaen ikke kunne brukes i Norge. I stedet ble det identifisert en ny 
holdningsskala som målte holdninger til utskrivelse fra LAR på grunn av rusbruk og 
begrensninger i inntakskriteriene. De som var mer tilbøyelige til å støtte utskrivning fra 
LAR på grunn av rusbruk og begrensninger i inntakskriteriene til LAR fikk merkelappen 
”rehabiliteringsorienterte”. Norske LAR-ansatte var mer ”rehabiliteringsorienterte” 
sammenliknet med de i ansatte i skadereduksjonstiltakene. Det var ingen samvariasjon 
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mellom holdninger og kunnskap, eller erfaring med metadon og/eller rusbehandling, i den 
norske undersøkelsen. 
Undersøkelsen av LAR viste store forskjeller mellom de ulike regionale LAR sentrene i 
antall pasienter per behandler, bruk av ansvarsgrupper, medikamentvalg (metadon eller 
buprenorfin), om forskrivende lege var fastlege eller LAR-lege, hyppighet av urinprøver og 
overvåket medikamentutlevering. De sentrene som hadde mer ikke-opioid rusbruk blant sine 
pasienter hadde mindre sosial rehabilitering (manglet egen bolig, uten arbeid, sosialhjelp 
som viktigste inntekt) blant sine pasienter. Disse forskjellene samvarierte med sentrenes 
holdninger til LAR. Det vil si at de ”rehabiliteringsorienterte” sentre hadde færre pasienter 
per behandler, mer hyppige urinprøver og flere ansvarsgrupper, samt bedre 
behandlingsresultater i form av mindre rusbruk og mer sosial rehabilitering sammenliknet 
med de andre sentrene. 
Diskusjon 
Den krysskulturelle tilpasningen av holdningsspørreskjemaet fra australsk-engelsk til norsk 
fremhevet farene ved å ta i bruk et spørreskjema i nye omgivelser uten en tilpasning til de 
nye omgivelsene. Holdningene funnet blant helsepersonell i fengselsvesenet i NSW var ikke 
gyldige i den norske undersøkelsen, i stedet fant man holdninger til utskrivelse fra LAR på 
grunn av rusbruk og begrensninger i inntakskriterier. I Norge var det ingen samvariasjon 
mellom målte holdninger og kunnskap og erfaring. Undersøkelsen av LAR viste variasjon i 
behandlingspraksis og behandlingsutfall mellom sentrene. Disse variasjonene samvarierte 
med de ansattes holdninger ved hvert regionale senter. Funnene fra denne avhandlingen 
indikerer at det eksisterer ulike behandlingskulturer som inkluderer holdninger og 
behandlingspraksis som kan påvirke behandlingsutfall.  
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Konklusjon 
Denne avhandlingen danner grunnlaget for fremtidige oppfølgingsstudier der endringer i 
ansattes holdninger til LAR og samvariasjonen med behandlingspraksis og 
behandlingsutfall kan måles. Samtidig indikerer funnene fra denne avhandlingen at 
fremtidig LAR forskning og evaluering bør måle ansattes holdninger til behandlingen fordi 
det ser ut til at dette er en viktig faktor som samvarierer med ansattes behandlingspraksis. 
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Preface 
The background for my interest in research and in particular staff attitudes towards opioid 
maintenance treatment began only three weeks into my Master of Public Health studies at 
the University of NSW in Sydney Australia in 2003. I visited the research centre “Centre for 
Health Research in Criminal Justice” at Justice Health located at Long Bay Jail in Sydney, 
NSW, Australia (picture below) as part of the course “Research Methods”. During my visit I 
was asked if I wanted to participate in the assessment of prison health staff attitudes towards 
and knowledge of methadone. I was unfamiliar with the field of drug dependence, 
methadone treatment, staff attitudes and a novice in research methods. However it was a 
great privilege to get the opportunity to learn and I therefore accepted the offer. 
 
Long Bay Jail in Sydney, NSW, Australia  
I was employed as a research assistant at the Centre for Health Research in Criminal Justice 
and Associate Professor Tony Butler, became my supervisor. I used the results from the 
assessment in the completion of my Master thesis. After the completion of the Master thesis 
and degree we began the work of writing up a paper. In 2007 the paper was published in 
Drug and Alcohol Review as the first paper published for this thesis. The same year I was 
employed as a PhD-candidate at Seraf- the National Centre for Addiction Research to 
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conduct a staff attitudinal study among Norwegian staff and this thesis is the result of that 
work. 
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Abbreviations and Definitions 
Addiction- “Impaired control over a reward-seeking (usually drug-taking) behaviour from 
which harm ensues. It is not all-or-none, but a matter of degree. Its severity can be assessed, 
amongst other things, by the severity of subjective urges or cravings, a frequency or 
intensity of behaviour that is causing harm and failure or serious attempts to limit or cease 
the activity” p 3 (11). 
Dependence syndrome-“ A cluster of physiological, behavioural, and cognitive phenomena 
in which the use of a substance or a class of substances takes on a much higher priority for a 
given individual than other behaviours that once had greater value. A central descriptive 
characteristic of the dependence syndrome is the desire (often strong, sometimes 
overpowering) to take psychoactive drugs (which may or may not have been medically 
prescribed), alcohol, or tobacco. There may be evidence that return to substance use after a 
period of abstinence leads to a more rapid reappearance of other features of the syndrome 
than occurs with nondependent individuals” p 4 (12). 
Abstinence-oriented methadone treatment- The main aim of treatment is abstinence from 
all drugs including treatment medications. Treatment may last from months to three to four 
years (13). Also known as methadone reduction treatment or time limited methadone 
treatment.  
Opioid maintenance treatment (OMT) – Opioids, most commonly methadone or 
buprenorphine are given in treatment of opioid dependence. Other opioids such as slow 
release morphine, LAAM (levo-alpha-acetyl methadol or levomethadyl acetate) or heroin 
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may be prescribed. Also known as opioid replacement treatment (ORT) or medication 
assisted treatment (MAT). 
Methadone maintenance treatment (MMT) - The same as opioid maintenance treatment, 
except that only methadone is prescribed. 
Rehabilitation in methadone treatment- Rehabilitation in methadone treatment was 
defined by Dole in 1966 as when a patient is living a responsible life, self-supporting in a 
steady job, and requiring little or no social help (14). 
Attitudes- There exist many formal definitions of attitudes (15). In this thesis attitudes are 
defined as” a psychological tendency to evaluate an object, person, institution or event 
positively or negatively” (15). Attitudes are internal to the person and can either be covert or 
overt and are generally expressed through cognitive, affective and behavioural responses 
(16).  
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1. Introduction 
In this thesis staff attitudes towards opioid maintenance treatment (OMT) among prison 
health staff in NSW, Australia and Norwegian OMT and harm reduction staff were 
investigated. An attitudinal instrument from Australian-English to Norwegian was cross-
culturally adapted. In addition variations between the 14 regional OMT centres within 
the Norwegian OMT programme were assessed. These variations and the associations 
with staff attitudes were also investigated.  
1.1 Opioid maintenance treatment (OMT) 
There are approximately 1.4 million (1.2–1.5 million) problem opioid users in the 
European Union (EU) and Norway (17). The majority of drug users that seek treatment 
in the EU are opioid users and most use heroin (17). There exists many theories and 
views on substance use and opioid dependence (11;18). Opioid dependence may be 
viewed as a medical problem that should be treated by the medical profession, as a 
criminal problem that should be controlled by sanctions and/or a social problem that 
should be treated mainly by social welfare services (13;19). In addition opioid 
dependence may be viewed as a cluster of physiological, behavioural and cognitive 
phenomena which should be treated through a multidisciplinary approach (12). 
Regardless opioid dependence is associated with an increased risk of mortality (20;21). 
Additionally intravenous (IV) drug users have an increased risk of co-morbidities such 
as HIV and hepatitis (22-27). 
Many and varied strategies in treating opiate dependence have been tried (13;19;28). In 
1884 Freud recommended the use of cocaine for morphine dependence (13). In 1898 
heroin, diacetylmorphine or diamorphine- a semi-synthetic derivative of morphine was 
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introduced as a treatment option for morphine dependence (13;19). At the same time 
morphine was prescribed for opium dependence (13;19;28). Prior to World War II 
methadone was synthesized for analgesia in Germany (29) and in 1949 methadone was 
found effective in withdrawing patients from heroin (29). However methadone treatment 
did not gain acceptance as a treatment for opiate dependence before Dole and colleagues 
had published several papers on the effectiveness of the treatment in the 1960’s (14;30-
33). Today OMT is recognised as an effective treatment for opioid dependence in most 
Western countries (20). Total number of clients receiving OMT in the EU and Norway 
in 2009 was estimated to be about 650 000 (17). This means that approximate 50% of all 
problem opioid users in Europe and Norway are currently in OMT.   
1.2 OMT a contentious issue 
Despite documented effectiveness, OMT have been and continuous to be a contentious 
issue in many countries (13;29;30). Introduction of OMT or changes in OMT policies 
are often based upon changes in society such as increased use of specific drugs, 
increased numbers of drug-related deaths or in response to the political climate (19;34). 
In Norway the political climate prior to the introduction of OMT emphasised the “drug 
free society” and abstinence-oriented treatment in the treatment of drug dependence (35-
37). However the political climate began to change in the light of the HIV epidemic and 
an increasing number of drug-related deaths in the mid 1980’s (38). Regardless there 
were strong resistance in the society against OMT. Thus OMT did not become 
nationally available before 1998 and only a small number of patients gained access in 
the early years of OMT in Norway (38).  
Norway is not the only country where the introduction of OMT was a contentious issue; 
US is another example. In the US it was by 1925 determined that it was a crime to 
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prescribe morphine in the treatment of opioid dependence (13;28;30). Despite the 
prohibition some physicians continued to prescribe opioids and by 1938 25 000 
physicians had been prosecuted for prescription of opioids and 3000 had served 
sentences (30). This illustrates the controversy in regards to OMT where some oppose 
OMT often based upon temperance moralism where abstinence from all drugs should be 
the main aim of treatment (39). While others believe it should be provided and some are 
even willing to risk imprisonment in order to provide treatment (30).  
The contentiousness of OMT is likely to be one of the reasons why OMT is organised in 
many different manners. Treatment may focus differently on harm reduction, social 
rehabilitation or abstinence from all drugs (14;40-42). If the aim of treatment is harm 
reduction the focus on treatment will be on reducing the harms of drug use (43;44). Dole 
and Nyswander defined a person as rehabilitated when a patient in methadone treatment 
was self-supported in a steady job, and required little or no social help and this would be 
the main aim in programmes where the main treatment objective is social rehabilitation 
(14).Whereas abstinence-oriented treatment with methadone or buprenorphine have the 
aims of abstinence from all drugs including treatment medication (41;42;45;46).  
Since there are variations in treatment aims, there are also differences in treatment 
provision. Some treatment programmes or clinicians prescribe mainly methadone, while 
others prescribe buprenorphine (47;48). Some discharge patients who continue to use 
drugs while in treatment, whereas others retain almost all patients regardless of drug use 
(40-42). There are also variations in opportunities of take-homes doses and frequency of 
urine drug screening (40;49;50). Importantly variations in OMT provision are found 
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between countries (51), within countries (52), and even between counsellors within the 
same treatment programme (53).  
Variations in provision and organisation of OMT affect treatment outcomes in various 
ways. Abstinence-oriented methadone programmes have been found to prescribe lower 
doses compared to long-term maintenance programmes (40;41;54). Treatment 
programmes that prescribe lower methadone doses (<60 mg) have had higher dropout 
rates and more drug use compared to programmes that provide higher doses (54-56). 
Smaller caseloads have been associated with more beneficial treatment outcomes such 
as less drug use and increased retention rates (53;57;58). In addition patients that receive 
intensified case management have had better outcomes compared to those that do not 
(59;60).  
1.3 Staff attitudes towards OMT and drug users 
Staff attitudes in the addiction field are widely researched (61-66). Attitudes are positive 
or negative evaluations of a particular entity (15;16). Someone who favours an issue 
such as harm reduction is viewed as holding a positive attitude towards this issue, 
whereas someone who disapprove of an issue such as harm reduction are viewed as 
holding a negative attitude towards this issue (15). Attitudes are generally expressed 
overt or covert through cognitive, affective and behavioural responses (15;16). They are 
not directly observable, but latent, hypothetical constructs which can be inferred from 
external observable responses such as attitudinal instruments (15;16). Attitudinal 
instruments are most commonly based upon standard attitudinal scaling techniques 
which results in a score that locates the respondent on an evaluative dimension 
according to the measured issue (e.g. harm reduction) (16;67).  
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The associations between attitudes and behaviour have been of particular interests to 
researchers (68-71), it is however important to be aware of the attitude-behaviour gap 
(71). This means that a person does not always act according to stated attitudes (72-79). 
Nevertheless there are some attitudes that are more likely to influence behaviour than 
others (68;70;80-83). Strong attitudes, the attitudes of the majority and perceived 
behavioural control (e.g. in decision making) are more likely to influence behaviour than 
weaker attitudes held by only one or few persons that perceive they don’t have any 
control over their situation (low perception of behavioural control) (16;84-86). This 
means that in treatment programmes such as OMT where there are strong staff attitudes 
shared by a majority of staff that perceive they have control over their work situation, in 
terms of decision making, it is likely that treatment will be influenced. 
The first investigations of staff and patients’ attitudes towards opiate dependence were 
published in the 1970 and early 1980’s (63;87-94). Some of these investigations (63;88-
90) found that both staff and patients had more positive attitudes towards drug-free 
treatment compared to long-term methadone maintenance. These attitudes mirrored the 
political climate at the time in many Western countries, where there were a large 
opposition between those that supported OMT and those that opposed this type of 
treatment (28;35;95).  
Some of those that opposed OMT could accept short-term methadone treatment if the 
long-term aim of treatment was abstinence from all drugs including methadone (41;42). 
To measure staff attitudes towards short-term and long-term methadone treatment an 
instrument was developed in New South Wales (NSW), Australia in 1996 (96). In this 
study staff that supported short-term methadone treatment were termed abstinence-
28 
 
oriented (96). The instrument (96) was later used in other studies in Australia (97-99), 
USA, (100-104), Netherlands (105), Germany (106), and Spain (107). These later 
studies found that support for abstinence-orientated principles in methadone treatment 
differed between age, level of education and experience from the addiction field. 
Younger staff with less education and less experience from the addiction field were 
more likely to support abstinence-oriented principles in methadone treatment 
(103;105;106). Other studies have also found that staff attitudes differed between 
treatment programmes, staff’s level of education and experience in the addiction field 
(108-110).  
A number of studies have assessed the association between staff attitudes and treatment 
provision. Abstinence-oriented staff have been more likely to prescribe lower 
methadone doses compared to maintenance-oriented staff (97;98;111). Provision of 
lower methadone doses (<60 mg) have been associated with lower retention rates 
(56;97;98). Key OMT staff members’ attitudes towards provision of OMT have been 
associated with prescriptions of benzodiazepines in the Norwegian OMT programme 
(6). In addition staff (programme directors, pharmacy staff, community staff, 
physicians) that have had positive attitudes towards drug using clients have been more 
likely to provide additional services such as needle-exchange services and HCV 
treatment compared to those that have had negative attitudes towards drug users (112-
118). Consequently staff attitudes towards drug users and treatment appear to influence 
treatment provision. 
Staff attitudes and the associations with treatment could be a result of organisational 
culture. Organisational culture is a collection of shared beliefs among members in an 
29 
 
organisation (119). The culture within an organisation has been described as a 
combination of attitudes, philosophy, and goals (120). Organisational cultures are likely 
to develop within a historical and societal context (13). When new staff begin their 
working career in the treatment programme it is likely that attitudes and treatment 
practices are influenced by those already employed in the organisation. In this manner 
specific organisational cultures develop and is maintained in each centre. 
1.4 Cross-cultural adaption of study instruments  
To use an instrument developed in one cultural context and to assume it is valid in 
another without modifications is a common mistake in research (7;9;10;121). One study 
assessed articles from two journals and found that bias due to an insufficient cross-
cultural adaptation process possibly existed in as many as three-fourths of the articles 
(122). It is assumed appropriate to develop content validity based upon experts’ advice 
and analysis while ignoring cultural understanding, to conform to the exact terms of 
standardized instruments in linguistic translations and to assume that all concepts are 
transferrable to all cultures (123). If these assumptions are followed the risk of 
information bias is introduced into a study (7;8).  
There are many reasons for why this may introduce bias into a study; expressions in the 
original instrument may not give any meaning in the new setting (7;8). A questionnaire 
that measure level of physical activity and uses snow activities such as skiing as 
examples may make no sense in countries where there are no snow (121). Additionally 
studies have found differences between cultures in how psychiatric symptoms such as 
bipolar and depression presents itself in patients (124;125). A cross-cultural adaptation 
process are therefore important also in studies where the settings appear to be cultural 
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similar because without a thorough cross-cultural adaptation process dissimilarities will 
not be detected.  
1.5 The Norwegian OMT programme 
There are between 8 800 and 12 500 injecting drug users in Norway (126). The 
Norwegian OMT programme was established as a national publicly funded treatment 
programme in 1998 (127). There was a rapid expansion from the initial intake of 240 
patients in 1998 to 4913 in 2008 (127;128). The programme comprises 14 regional 
centres that are subject to the same treatment standards specified in government 
guidelines (128).  
There were some attempts to introduce methadone in the treatment of opioid 
dependence prior to 1998 (36). In 1969 a public hospital that treated opioid dependence 
prescribed methadone to some of their patients (35). The hospital concluded that 
methadone treatment was difficult when there were no other collaborating parties 
involved except the hospital, thus this type of treatment was terminated (38). There was 
another attempt of methadone maintenance treatment in 1971-72 (38). Five opioid 
dependents were prescribed methadone in a psychiatric hospital, but also this treatment 
attempt was short-lived (38). In 1976 the Department of Health decided it was against 
regulations to prescribe methadone in the treatment of opioid dependence (35;36). 
Instead there was an emphasis on and increase in abstinence-oriented treatment 
approaches (35;36). 
The discussions in regard to methadone treatment reoccurred in the light of the HIV 
epidemic and an increasing number of drug-related deaths in the mid 1980’s (36;37). 
The Director of Health at the time, established a working group to assess the possibility 
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of providing methadone treatment, but the report based on this assessment was never 
published (36;38). Nevertheless some practitioners began to prescribe methadone to 
HIV positive opioid dependents (38). In 1991 methadone maintenances treatment was 
established as a trial project for HIV positive opioid dependents in Oslo (129). In 1994 
another trial project was established in order to reach opioid dependents that were hard-
to-treat (130;131). Those that gained access into this latter project had to be above 30 
years old, had to have at least ten years of opioid dependence and failed several 
abstinence-oriented treatment attempts (131). Based upon the results from these two trial 
projects OMT became nationally available in 1998; however the limitations on intake 
criteria continued (127).  
The initial intake criteria were that only persons above 25 years with more than 10 years 
of opioid dependence that had failed abstinence-oriented treatment were accepted into 
treatment (127). These criteria were subsequently modified; the 25 years age criterion 
was removed and patients with less than 10 years of opioid dependence were included 
(47). The many years of heated debate before the introduction of OMT may have 
coloured staff’s attitudes and beliefs towards OMT. Possibly the development of the 
Norwegian OMT programme were not only influenced by the legal framework and 
structure, but also by staff attitudes and beliefs.  
Patient treatment relies on long-term three-party collaboration between an OMT centre, 
a GP and social services (47). Patients have until recently, had to establish contact with 
social welfare services and a GP to become applicable for OMT (47). Once an opiate 
dependent person has been accepted and stabilized into OMT a GP may be the 
prescribing doctor, but treatment should be supervised by a regional OMT centre (47). 
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Initial acceptance into treatment and treatment initiation are always the responsibilities 
of the OMT centre (47). A consequence of the long-term three party collaboration is that 
patients are not entirely free to choose their treatment centre due to logistical and 
geographical challenges (132). This means that patients are required to accept their local 
centre’s treatment standards and practices, since there is only one OMT centre available 
in each geographical region. 
To support consistency of treatment between the regional centres, managers from all of 
the centres meet several times a year. Centres that differ from the other centres in 
treatment practices or outcomes are identified through annual assessments and reasons 
for divergency are discussed. There are no formal regulatory body to ensure that centres 
follow the same treatment standards. However patients may file individual complaints to 
their regional board of health supervision. The board’s decisions are normative for all 
centres and thus treatment practices in all centres may be changed or modified due to 
such complaints.  
In 2004 a report was published that indicated that there were differences in treatment 
practices and treatment outcomes between the regional centres (2). Annual assessments 
of the OMT programme continued to document treatment differences between the 
regional centres (3-5;128). Based upon this report and the persistent documented 
differences between the centres, it was decided to establish formal guidelines for OMT 
in Norway (133). The guidelines were published in 2010 (134), but it is yet to be known 
whether they will reduce the differences found between the centres or not. Possibly there 
are other factors than lack of guidelines that are associated with the treatment 
differences within the Norwegian OMT programme. It is possible that one of these 
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factors is staff attitudes towards OMT. Therefore one of the main aims of this thesis was 
to investigate staff attitudes towards OMT in the Norwegian OMT programme and to 
assess if there were any associations with the documented treatment differences between 
the regional OMT centres. 
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2. Background and Objectives 
2.1 Background for the three studies included in this thesis 
2.1.1 Australian prison health staff study (Study I) 
OMT was a contentious issue in the NSW; Australian prison context in 2003. Some 
prison governors opposed OMT on the grounds that it served to promote drug use; 
instead they preferred complete abstinence within their facility. There were also reports 
that some prison health staff discouraged prisoners to enter or remain in OMT (1). 
Justice Health was responsible for providing health care services to prisoners within 
NSW; Australia. This organisation was therefore one of the biggest prescribers of 
methadone in NSW, with more than 1100 prisoners on the programme. Consequently 
Justice Health found it necessary to assess staff attitudes towards OMT to address the 
issue that some prison health staff discouraged prisoners from OMT. It was therefore 
decided to investigate prison health staff attitudes towards and knowledge of methadone. 
2.1.2 Norwegian attitudinal staff study (Study II)  
The Norwegian OMT programme is assessed annually for quality assurance purposes. 
These assessments had documented persistent differences in treatment practices and 
outcomes between the 14 regional centres since 2004 (2;4;5). In 2004 key personnel, 
mainly managers’ attitudes were assessed through telephone interviews, but no formally 
structured instrument was used (2). This study found that centre managers differed in 
their views on what to do if a patient had used drugs while in treatment. Some would 
discharge patients if they had used cannabis or alcohol and others would not. Some 
would tolerate benzodiazepine use, others would not. Centres were labelled “liberal”, 
“restrictive” or “neutral” based upon this assessment (2). Another study found that 
centres labelled “liberal” had more benzodiazepines prescribed among their patients 
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compared to other centres (6). However no other characteristics or outcomes were 
assessed. Consequently there existed no formal study that assessed staff attitudes among 
all OMT staff and that had investigated the associations between staff attitudes and 
treatment characteristics, clinical practices and patient outcomes. It was therefore 
decided to assess Norwegian staff attitudes towards OMT using the same attitudinal 
instrument as in the Australian prison health staff study. 
2.1.3 Norwegian OMT programme assessment (Study III) 
In the Norwegian OMT programme possible patterns between centres in terms of 
clinical practices and outcomes had not previously been explored and described in full 
detail. Since 2004 annual assessments of the OMT programme had documented 
treatment differences between centres (2-5). However in these assessments the 
differences were listed as frequency reports, but the patterns and associations between 
treatment and treatment differences between centres had not been addressed. In 2007 a 
description of the national OMT programme was published, but this paper mainly 
described the structure of the programme and did not state explicitly what differences 
existed between centres (47). Another paper from 2007 described differences between 
regional centers in terms of prescriptions of benzodiazepines among their patients; 
however other differences between centres were not explored (6). Consequently there 
existed some knowledge that differences between centres existed, but there was a lack of 
an overall knowledge in what specific type of differences existed between centres and if 
there were any patterns between treatment characteristics, clinical practices and 
outcomes within the Norwegian OMT programme. Thus it was decided to formally 
assess the patterns in treatment differences between the regional OMT centres, based 
upon data from the annual assessments using more detailed analysis. 
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2.2 Objectives 
The overall aims of this thesis were to investigate staff attitudes towards and knowledge 
of OMT in a prison context in NSW, Australia and among Norwegian OMT and harm 
reduction staff. It also aimed to cross-culturally adapt an attitudinal instrument from 
Australian-English into Norwegian. Additionally it aimed to explore differences in 
treatment organisation, clinical practices and outcomes within the Norwegian opioid 
maintenance treatment (OMT) programme and to assess staff attitudes and its possible 
associations with treatment organisation, clinical practices and outcomes.  
The specific aims were: 
I. To assess and describe attitudes towards and knowledge of OMT among prison 
health staff in NSW, Australia (Study I; paper I). 
II. To cross-culturally adapt a study instrument from Australian-English to 
Norwegian and to assess and describe attitudes towards and knowledge of OMT 
among Norwegian OMT and harm reduction staff (Study II; paper II). 
III. To describe treatment organisation and clinical practices within the Norwegian 
national OMT programme. Furthermore to investigate possible associations 
between these factors and drug use and social rehabilitation outcomes among 
patients treated within the programme (Study III; paper III).  
IV. To assess if there were differences in staff attitudes between OMT centres, and 
to investigate the associations of staff attitudes with treatment organisation, 
clinical practices and outcomes (Study II and III; paper IV). 
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3. Material and Methods 
3.1 Setting and Design 
The prison health staff study (study I) was a cross-sectional mail out survey among 396 
staff employed by Justice Health which was the correctional health services in NSW; 
Australia in May and June 2003. Respondents returned the questionnaires in prepaid 
envelopes. 
The Norwegian staff study (study II) was a cross-sectional study where all eligible staff 
(n=140) from the national OMT programme and harm reduction services (n=180) in 
Oslo were invited to participate. The programme comprised 14 regional centres that 
employed from three to thirty-three staff members. Two of the centres were merged 
because they had a joint staff group at the time of the study. Harm reduction services 
included street clinics, needle-exchange programmes, injecting rooms and housing 
facilities. Harm reduction services included 12 facilities and employed between six to 30 
employees. Data were collected between August and November 2007. Prior to data 
collection managers in each facility were contacted and asked if they and their staff 
wanted to participate in the study. In some facilities (12 OMT centres and 7 harm 
reduction facilities) the researcher was invited to give information during staff meetings 
when most staff were present, thereafter staff completed the questionnaires. Prepaid and 
anonymous envelopes addressed to the researcher were attached to each questionnaire. 
Responders could choose not to respond to the survey by returning an incomplete 
questionnaire in the envelope. Staff that were absent returned the questionnaire by mail. 
In other facilities (1 OMT centre and 4 harm reduction facilities) staff received 
information during staff meetings and thereafter returned the questionnaire by postal 
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mail or email. In addition in one harm reduction facility managers were informed by 
email and thereafter staff returned the questionnaire by postal mail. No names were 
collected, but number of staff that had completed the questionnaire at each facility was 
recorded. Centre managers were followed up to encourage that all staff returned 
questionnaires. 
The assessment of the Norwegian OMT programme (study III) used data collected in the 
OMT programme assessments which is an annual national cross-sectional multicentre 
study. The study comprised all 14 regional OMT centres within the Norwegian OMT 
programme. To answer aim III (paper III) data collected for the annual assessment 2008 
were used. To answer aim IV (paper IV) data collected for the annual assessment 2007 
were used, this was because data from the Norwegian staff study were collected the 
same year.  
3.2 Study instruments 
3.2.1 The original attitudinal instrument 
The prison health staff study (study I) and the Norwegian staff study (study II) used an 
instrument developed in NSW, Australia in 1996 (96) (appendix 1). The original 
instrument comprised two attitudinal scales; the 14-items “Abstinence-orientation” scale 
and the six items “Disapproval of drug use” scale (appendix 1). The “Abstinence-
orientation” scale comprised two almost perfectly correlated dimensions; attitudes 
towards abstinence-oriented policies and support for disciplinary actions if programme 
rules were broken (96). Cronbach’s alpha for the “Abstinence-orientation” scale was  
=0.89 (96) and for the “Disapproval of drug use “ scale was 0.75 (96). When the 
instrument was developed there was a positive correlation between the “Abstinence-
orientation” and “Disapproval of drug use” scale (r=0.64) (96).  
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The responses were recorded on a five-point Likert scale ranging from “strongly 
disagree=1” to “strongly agree=5” (96). A sum score was calculated for each of the two 
attitudinal scales by dividing number of completed items with the total score (96).  
Additionally the instrument comprised a 12-item knowledge scale. This scale tested 
respondents’ knowledge of the benefits and risks of methadone treatment (96). The scale 
was characterised by statements such as “Methadone, when given as a maintenance 
programme, reduces (“blocks”) the effects of heroin” (96) (appendix 1). The items were 
scored “1” for correct answer, “0” for “uncertain” and “-1” for incorrect answer (96). 
The theoretical score range was -12 to 12. In the Australian prison health staff study 
(study I) and the Norwegian staff study (study II) the “knowledge around risks and 
benefits of methadone” scale (know scale) was reduced to 11 items due to discussions 
around the item “Withdrawing from methadone “cold turkey” is definitely worse than 
similarly withdrawing from heroin” (Personal communication Caplehorn 2003). 
Consequently the theoretical score range for the “know scale” was -11 to +11. 
In the Australian prison health staff study (study I) another knowledge scale that 
measured knowledge of methadone toxicity (Tox scale) was added to the instrument. 
This scale was developed in 1998 (98) (appendix 1). The theoretical score range for this 
scale was -13 to 13. The instrument used in the prison health staff study is found in 
appendix 2. 
Since the original study instrument was developed in 1996 there had become an 
increased focus on harm reduction (135). Items that measured support for harm-
reduction principles were therefore added to the instrument in the prison health staff 
study. In addition there had been an increase in the use of buprenorphine rather than 
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methadone in community OMT programmes (136;137); two questions related to 
buprenorphine were therefore added. Also naltrexone was used increasingly to prevent 
relapse in opioid-dependent patients (138;139), thus two questions on naltrexone were 
included. These seven items were scattered throughout the 52-item instrument, but were 
not part of any of the scales.  
In the Norwegian attitudinal staff study (study II) the original instrument (96) was cross-
culturally adapted according to guidelines on cross-cultural adaptations (7-10). These 
suggested guidelines are found in appendix 3. The findings from the cross-cultural 
adaptation process were part of the results and were therefore presented in the results 
section both in paper II and in this thesis. In this process 12 attitudinal statements were 
added to the instruments. Some of these items were variants of the original items, while 
other items introduced new concepts. The additional items were placed after the original 
items and thus did not alter the instrument’s original structure. The instrument used in 
the Norwegian staff study (study II) is found in appendix 4. 
3.2.2 The instrument used in the Norwegian OMT programme assessment (Study III) 
In the annual assessments of the OMT programme a 53-item questionnaire is completed 
for each patient. The instrument was originally developed in 2001 and taken into use in 
2002  as a measure in the annual assessment of the Norwegian OMT programme (140). 
The variables within the questionnaire were developed on the basis that this should be 
the minimum information that the case manager should have of their patients. 
Information on patients’ drug use previous four weeks were based mainly on urine drug 
screening results. The patients’ case manager either at the OMT centre or at the social 
service centre completed the questionnaire for each patient, and if possible the 
instrument was completed in collaboration with the patient. The questionnaire’s inter-
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rater reliability was assessed in 2004 (140), and items with low reliability (< 0.60) were 
adjusted accordingly.  
3.3 Study factors and outcome variables 
3.3.1 Prison health staff study (study 1) 
In this study demographic information included age, employment period, qualifications 
in the treatment of drug dependence, frequency of dispensing methadone and position 
within the organisations (public health nurse, mental health nurse, general nurse, nurse 
unit manager, doctor, management or drug and alcohol position). The outcome variables 
were staff attitudes towards abstinence-oriented principles in methadone treatment, 
attitudes towards drug use in the society, knowledge around risks and benefits of 
methadone treatment and knowledge around methadone toxicity.  
3.3.2 The Norwegian staff study (study II)   
In this study OMT staff were compared to staff employed in harm reduction facilities. 
Demographic variables were staff category, age category, level of education, time 
worked at current workplace, time worked in the addiction field. The outcome variables 
were staff attitudes towards OMT and knowledge around risks and benefits of 
methadone treatment.  
3.3.3 The assessment of the Norwegian OMT programme (study III) 
In this study treatment organisation included number of patients and staff and caseload. 
Clinical practices included number of patients prescribed methadone or buprenorphine, 
median medication dosages, number of patients prescribed their medication either from 
a GP or the OMT doctor. Additionally number of patients’ urine drug screened at least 
once a week and frequency of supervised dispensing were included. Supervised 
dispensing (observed intake of medication) gives an indication of take-home privileges 
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among patients. OMT centres with high frequency of supervised dispensing will have 
less take-home doses compared to centres with lower frequency.  
Patient outcomes included the treatment termination rate and number of patients who 
had used opioids, benzodiazepines, cannabis and central stimulants previous four weeks. 
Number of patients with long-term living arrangements, number of unemployed 
patients, and number of patients with social security benefits as main income were also 
included.  
3.3.4 The Norwegian staff study and the assessment of the OMT programme (study II 
and III) 
In this study each centre’s mean attitudinal scores were assessed. The attitudinal scores 
were based upon the scale developed in the Norwegian staff study (study II). It was 
decided to label those with the lowest mean scores on the scale “harm reduction-
oriented” and those with the highest mean score “rehabilitation-oriented”. These labels 
were based upon the content of the attitudinal scale. This means that the “harm 
reduction-oriented” would be more likely, compared to “rehabilitation-oriented” to 
disagree that drug use was a reason for disciplinary discharge and more likely to agree 
that an OMT programme should be available to all opiate dependents.  
Centres were divided into three groups based upon their mean attitudinal scores, with 
equal number of centres in each group (4-5-4). The four centres with the lowest scores 
were termed "harm reduction-oriented" and the four centres with the highest scores were 
termed "rehabilitation-oriented". The five centres that had attitudinal scores between the 
two opposing groups were termed "intermediate" centres. 
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Centre organisation and clinical practices included patient/staff ratio, methadone and 
buprenorphine dose, and interdisciplinary meeting attendance among patients as well as 
supervised dispensing and urine drug screening at each OMT centre. Drug use previous 
four weeks and social functioning variables were outcome variables. Drug use variables 
were opioid, benzodiazepines, central stimulants and cannabis use previous four weeks. 
These data were measured by urine drug screening and self-report. Social rehabilitation 
was measured using current employment status, social security benefits as main income 
and type of living arrangements. Patient retention was measured indirectly using the 
treatment termination rate.  
3.4 Data analysis 
3.4.1 Prison health staff study (study I) 
Summary statistics were calculated using SPSS version 11 (141). The abstinence-
orientation and disapproval of drug use scales’ structural validity were tested together in 
a confirmatory factor analysis model using unweighted least squares (Proc Calis, SAS 
Institute Inc, Cary, NC). The decision of overall model fit was based upon the following 
goodness-of-fit indices; root mean square residual (RMSR), Goodness of Fit Index 
(GFI), GFI adjusted for degrees of freedom and parsimonious GFI (142). 
Analysis of variance was used to examine the association between mean scores on the 
various scales and the different staff categories. Tamhane T2 was used as a post-hoc 
analysis when there was a significant difference between the different staff categories 
mean scores. Pearson’s correlation coefficient was used to examine the association 
between the scores on the various scales; t-tests were used to examine differences in 
mean scores on the various scales based on whether staff had community experience or 
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additional training and to test for differences between this study and previous Australian 
studies. 
Additional analysis were completed for this thesis; the linear regression coefficient (b) 
and 95% CI were calculated between attitudinal and knowledge scores and all 
demographic variables such as staff category and additional training/experience.    
3.4.2 Norwegian staff study (study II)  
Descriptive statistics were calculated using the statistical software SPSS version 16 
(143). Data were assessed using exploratory and confirmatory statistical analysis. 
Initially the 14 original abstinence-oriented items were tested through confirmatory 
analysis. The confirmatory analysis were based on the one-factor model from the 
original instrument (96). Thereafter both original and new items were assessed using 
exploratory factor analysis. The model retrieved through exploratory factor analysis was 
tested through confirmatory analysis. Exploratory factor analysis were completed in the 
statistical software SPSS version 16 (143). Confirmatory analysis were completed in the 
statistical software AMOS graphic version 17 (144). 
The main aim of the exploratory factor analysis was to find an instrument that could 
assess attitudes that were important to Norwegian OMT staff. The analysis were 
completed using principal axis and oblique rotation methods (promax and direct oblim). 
Promax and direct oblim are the two only oblique rotation methods available in SPSS 
version 16 (143). Both rotation methods were used to assess if the data were sensitive to 
rotation method. The correlation matrix and factor loadings were used to decide which 
items to retain. A scree plot was used to decide the number of factors to retain. 
Additionally the Cronbach’s alpha () was assessed.  
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Confirmatory analysis were completed through structural equation modelling using 
maximum likelihood analysis. The maximum likelihood method assumes that data are 
continuous and have multivariate normal distribution (145-147). Data were checked for 
normality both graphically and by assessing univariate and multivariate skewness and 
kurtosis.  
The statistical software AMOS version 17 does not handle missing values when 
modification indices are estimated (144). Thus a missing value pattern was generated for 
all items to assess if values were missing at random. If values were missing at random it 
would be appropriate to delete missing values listwise for the confirmatory analysis. 
Additionally a high number of missing items not missing at random could indicate that 
one or more items were not understood by the respondents. Furthermore a high number 
of the response “uncertain” could indicate that an item was problematic. Identification of 
problematic items at this stage of the cross-cultural adaptation process, would suggest 
that the pre-test of the instrument had been insufficient.   
The sample data included two different groups (harm reduction staff and OMT staff), 
thus multi-group analyses were applied (145;147;148). The latent mean was assessed 
with OMT as reference group. Factor mean was constrained to zero in OMT staff and 
freely estimated in harm reduction staff. While factor loadings, item intercepts and 
measurement error means were constrained to zero in both groups. Factor covariances 
and measurement error variance were freely estimated in both groups. 
In this study the decision of overall model fit was based upon four fit indices. These 
indices were the comparative fit index (CFI) (149), the Tucker-Lewis index (TLI ) (150) 
and the root mean square error of approximation (RMSEA) (151). The average variance 
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extracted (AVE) (152) was also assessed. In order to decide best model fit in the 
multigroup analysis Aikaike’s information criterion (AIC) (153;154) and the Browne-
Cudek criterion (BCC) (155) were assessed. A more detailed description of these fit 
indices is found in paper II. 
3.4.3 The assessment of the Norwegian OMT programme (study III) 
Aggregated information (number of patients for each variable and total number of 
patients) for each regional centre (14 centres) was available for analysis. Only 
completed items were included in the analysis. Thus the total number of respondents for 
each item varied from the total number of patients at each centre. Based upon these data 
it was possible to calculate the prevalence in each centre for each item. Data was 
presented as median (range) across all centres. The linear regression coefficient (b) and 
95% CI were calculated between outcome and demographic variables.  
Some of the outcome variables tended to be correlated. Principal component analysis 
(PCA) was conducted to assess if it was possible to reduce the number of outcome 
variables into components. PCA computes linear combinations, i.e. weighted sums, 
among the variables in question, that explain as much variance as possible. Often the 
first principal component describes a sufficient amount of the total variation that it 
provides a good representation of the variables (156). Descriptive statistics and linear 
regressions analysis were calculated in SPSS 16.0 (143) and PCA in the open source 
computer software R (157). 
3.4.4 The Norwegian staff study and the assessment of the OMT programme (study II 
and III) 
Descriptive statistics and regression analysis were completed using SPSS version 16.0 
(143). A missing value pattern was generated for all items. Staff attitudes were 
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investigated by linear regression analysis with mean attitudinal score as dependent 
variable and age, gender, staff category, years of education, time worked in the addiction 
field and OMT centre as independent or predictor variables. Prevalence estimates were 
reported (158). Differences between centres were calculated using prevalence difference 
and 95% CI.  
3.5 Ethics  
Study I was a study of health staff employed at Justice Health in NSW, Australia. This 
study was undertaken as part of a quality exercise of health staffs knowledge and 
attitudes towards methadone treatment and it was therefore not formally necessary to 
obtain approval from an Ethics committee. Regardless the study followed guidelines 
given by the Australian National Health and Medical Research Council (1999) (159) and 
was completed in accordance with the National Health and Medical Research Council 
Act 1992 (160).  
Study II was approved by the Norwegian Regional Ethics Committee and the Data 
Inspectorate in 2007. Prepaid and anonymous envelopes addressed to the researcher 
were attached to each questionnaire. Responders could choose not to respond to the 
survey by returning an incomplete questionnaire in the envelope. No names were 
collected, but number of staff that had completed the questionnaire at each facility was 
recorded. Centre managers were followed up to encourage that all staff returned 
questionnaires. Participants received written and oral information about the study. 
Respondents consented to participate in the study by submitting the questionnaire. The 
questionnaire was semi-anonymous. This means that the name of the facility and other 
demographic variables made some staff theoretically identifiable. Participants were 
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promised full anonymity upon distribution of results. Demographic variables that 
identify respondents will therefore be deleted upon completion of the project. 
Study III was part of the data collected for the annual assessments of the Norwegian 
OMT programme at the Norwegian Centre for Addiction Research (Seraf) and data were 
only available as aggregated information published in the annual OMT reports. This 
means that no individual information was available and it did therefore not require 
informed consent or approval from the Norwegian Regional Ethics Committee and the 
Data Inspectorate. 
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4. Summary of results 
This section responds to the aims of this thesis. The results presented in this section are 
therefore sometimes presented in a different manner to the results presented in the four 
articles included in this thesis. 
4.1 Aim I 
To assess and describe attitudes towards and knowledge of OMT among prison health staff 
in NSW, Australia (Study I) 
Overall response rate was 51%. 77% of the respondents were women and 74% were more 
than 40 years old. 28% had been employed in Justice Health between 2 to 5 years, whereas 
43% had been employed more than 5 years. 79% had not received any additional training in 
regards to OMT and 78% did not have any experience from a community OMT programme. 
The mean “abstinence-orientation” scale (range 1-5) score was 2.86 (95% CI 2.76; 2.96) 
and 3.29 (95% CI 3.18; 3.40) for the “disapproval of drug use” scale (range 1-5) score. The 
mean scores on the “knowledge of risks and benefits of methadone” scale (range -11-11) 
was 2.65 (95% CI 2.36; 2.95) and 4.60 (95% CI 4.20; 5.00) on the “knowledge of 
methadone toxicity” scale (range -13-13).  
There was a correlation between the scores on the “abstinence-orientation” scale and the 
“disapproval of drug use” scale (r=0.60, b=0.52 95% CI 0.42; 0.61). This means that staff 
that supported abstinence-oriented principles in methadone treatment were more prone to 
disapprove of drug use compared to those that were less supportive. In addition it was a 
negative correlation between the scores on the “knowledge about the risks and benefits of 
methadone” scale and the scores on the “abstinence-orientation” scale (r= -0.61, b= -0.20 
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95% CI -0.24; -0.16). This means that those that had less knowledge about the risks and 
benefits of methadone were more likely to support abstinence-oriented principles in 
methadone treatment. There was also an association between scores on the “knowledge 
about the risks and benefits of methadone scale and the scores on the “disapproval of drug 
use” scale (r=-0.36, b=-0.14 95% CI -0.19; -0.09).  
Respondents that had worked in community methadone programmes were less inclined to 
be pro-abstinence than those who did not have this experience (r=17, b=0.28 95% CI 0.05; 
0.52), less likely to disapprove of drug use (r=0.16, b=0.31 95% CI 0.04; 0.58) and more 
knowledgeable about the risks and benefits of methadone (r=0.24, b=--1.22 95% CI -1.92; -
0.52).  
In paper I R square (r2) was mistakenly reported as Pearson R in the presentation of 
correlations between the four scales (attitudinal and knowledge). This is corrected and the 
correct Pearson R is reported in this thesis. This means that the correlation coefficient was 
higher than what it appeared to be in paper I. However this only strengthens and does not 
alter the conclusions of this paper. 
4.2 Aim II 
To cross-culturally adapt a study instrument from Australian-English to Norwegian and to 
assess and describe attitudes towards and knowledge of OMT among Norwegian OMT and 
harm reduction staff (Study II). 
The cross-cultural adaptation process included investigation of conceptual and item 
equivalence. Two forward and two back-translations were synthesized and compared by an 
expert committee. Thereafter the instrument was pretested and adjusted accordingly. The 
final questionnaire was administered to Norwegian OMT and harm reduction staff. All 
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OMT staff (100%) and 72% of harm reduction staff participated in this investigation. 2/3 of 
the respondents were women. OMT staff were older than harm reduction staff, with the 
majority of staff (60%) in the age category 40 to 59 years. All OMT staff had more than 
three years of tertiary education, whereas 43% of harm reduction staff had less than three 
years of tertiary education. In addition more OMT staff had worked more than six years in 
the addiction field compared to harm reduction staff (62% versus 41%). 
The attitudes found among Australian prison health staff; attitudes towards abstinence-
oriented principles in methadone treatment and disapproval of drug use were not valid in the 
Norwegian setting. Instead a new two-factor attitudinal scale was produced through 
exploratory factor analysis. This scale measured support for disciplinary discharge from 
treatment due to in-treatment drug use (“compliance”) and limitations on intake criteria 
(“accessibility”) in OMT (appendix 5). 
The mean “compliance” score for OMT staff was 3.38 (95% 3.23; 3.52) and mean 
“accessibility” score was 3.51 (95% CI 3.40; 3.62). In harm reduction mean “compliance” 
score was 2.54 (95% CI 2.42; 2.67) and mean “accessibility” score was 2.49 (95% CI 2.39; 
2.59). Multigroup analysis showed that the attitudinal scale differed in all parameters 
between the two groups. In other words OMT staff were more likely to support disciplinary 
discharge from treatment due to in-treatment drug use and limitations on intake criteria 
compared to harm reduction staff.  
Norwegian OMT staff had higher mean “knowledge about risks and benefits of methadone” 
(range -11-11) scores (6.19 95% CI 5.80; 6.58) compared to harm reduction staff (3.43 95% 
CI 2.92; 3.93). Linear regression analysis did not find any associations between attitudinal 
scores and knowledge scores, staff category, age or experience in the addiction field.    
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4.3 Aim III 
To describe treatment organisation and clinical practices within the Norwegian national 
OMT programme. Furthermore to investigate possible associations between these factors 
and drug use and social rehabilitation outcomes among patients treated within the 
programme (Study III) 
4913 patients were in treatment in the 14 regional OMT centres at the end of 2008. The 
overall response rate in the centres was 81%. The median patient age was 41 years, and 30% 
of the patients were women. There were no major differences between OMT centres in 
patients’ age and gender distribution. 
Number of patients ranged from 124 to 1106 and caseload varied from 26 to 231 between 
centres. The involvement of a GP as the prescribing doctor varied from 3% to 100%. Choice 
of agonists (methadone or buprenorphine) also varied between the centres, however all 
centres prescribed high-dose treatment. Methadone dose ranged from 90 mg to 120 mg and 
the buprenorphine dose ranged from 16 mg to 24 mg.  
Three centres supervised dispensing on average (median) twice a week, whereas four 
centres supervised dispensing four times a week (median). Urine drug screening at least 
once a week ranged from 90% of all patients in one centre to 43% of all patients in another 
centre.  
Use of benzodiazepines ranged from 16% to 63% between the centres, while use of 
cannabis ranged from 12% to 49%. There were also variations between centres in the use of 
central stimulants (range 8%-24%) and opioids (range 3%-24%).  There was a 28% 
difference between the centres with least and most patients with stable long-term living 
arrangements. Unemployed patients ranged from 54% to 86%, while patients with social 
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security benefits as main income ranged from 3% to 31% between the centres. The median 
treatment termination rate across all centres was as low as 4%, but it ranged from 1% to 
18%.  Centres with high use of benzodiazepines, cannabis and central stimulants  had less 
social rehabilitation in terms of long-term living arrangements, unemployment and social 
security benefits as main income (r=0.74, b=0.74 95% CI 0.31; 1.16). 
4.4 Aim IV 
To assess if there were differences in staff attitudes between OMT centres, and to investigate 
the associations of staff attitudes with treatment organisation, clinical practices and 
outcomes (Study II and III) 
In this study the Norwegian OMT staff attitudes towards OMT were assessed separately 
from the data collected on Norwegian harm reduction staff. Staff attitudinal scores varied 
between centres. In the linear regression analysis the variable “regional OMT centre” was 
the only independent variable that was associated with staff attitudes (r=0.44, b=0.06 95% 
CI 0.04; 0.08), none of the other independent variables such as gender, age or staff category 
were associated with the attitudinal scores. 
The four centres that were labelled “rehabilitation-oriented”, because they had higher 
attitudinal scores compared to the other centres, comprised 1049 patients. The four centres 
with the lowest attitudinal scores (“harm reduction-oriented”) comprised 1980 patients. 
Centres between the two opposing groups in attitudinal scores (“intermediate”) comprised 
1513 patients.  
“Rehabilitation-oriented” centres had smaller caseloads, more frequent urine drug screening 
and increased case management (interdisciplinary meetings). In addition these centres had 
less drug use and more social rehabilitation among their patients in terms of long-term 
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living arrangements, unemployment and social security benefits as main income. 
“Intermediate” centres had the lowest treatment termination rate. More than half of the 
patients (55%) had used benzodiazepines in the “harm-reduction oriented” centres previous 
four weeks compared to 32% in “rehabilitation-oriented” centres. Furthermore 17% more 
patients were unemployed, 12% more patients had social security benefits as main income 
and 15% less patients had long-term living arrangements in the “harm reduction-oriented” 
centres compared to the “rehabilitation-oriented” centres. 
4.5 Brief summary of main findings 
Aim I 
Among participating prison health staff positive attitudes towards abstinence-orientated 
principles in methadone treatment were associated with less knowledge around risks and 
benefits of methadone and less experience with methadone treatment in the community. 
Aim II 
The cross-cultural adaptation process highlighted the importance of such a process as the 
original Australian attitudinal scales were not valid in the Norwegian setting. Instead a new 
two-factor attitudinal scale was identified. Norwegian harm reduction staff were less likely 
to support discharge from treatment due to drug use and more likely to support an OMT 
programme open to all opioid dependents compared to Norwegian OMT staff. Norwegian 
OMT staff had more knowledge of methadone compared to harm reduction staff.  
Aim III 
There were large differences between the 14 regional OMT centres in the treatment 
characteristics, patients’ drug use previous four weeks and social rehabilitation. Centres 
with high levels of drug use had lower levels of social rehabilitation among their patients. 
Aim IV 
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There were differences between the regional OMT centres in staff attitudes and these 
differences were associated with variations in treatment organisation, clinical practices and 
outcomes. “Rehabilitation-oriented” centres had smaller caseloads, more frequent urine drug 
screening and increased case management. In addition these centres had less drug use and 
more social rehabilitation among their patients. 
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5. Methodological considerations 
Methodological considerations include evaluations of internal and external validity of 
research studies. Internal validity is the inference made in the population studied (161). This 
inference may be threatened by study design, selection bias, information bias and 
confounding (158;161). External validity depends on the internal validity of a study (161). It 
concerns generalizations such as to what populations the conclusions from a study may be 
generalized (158;161) 
5.1 Study design 
The three studies, included in this thesis, all had a cross-sectional study design. This means 
that data was collected at a specific point in time, without either forward or backward timing 
(158;161). A cross-sectional design limits inference to causality (158;161). It is however 
possible to measure strength of associations between independent and dependent variables, 
but normally not to determine what preceded the other (161). Thus the three studies were 
limited by the cross-sectional design in terms of inference to causality.  
5.2 Selection bias 
There were large variations in response rates between the three studies. In the prison health 
study (study I) all staff were invited, but only 51% participated. This increases the 
possibility that study participants differed from non-participants, which is the concern in 
regard to selection bias (162). No data were formally collected on reasons why some staff 
did not participate. However, two questionnaires were incomplete with comments that 
respondents refused to participate in a study that was not anonymous. The questionnaires, in 
this study, were individually labelled with numbers to facilitate follow up. These numbers 
were identification numbers that corresponded to the names of the individual staff in the 
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organisation. Thus it is likely that some staff did not participate due to uncertainties around 
the anonymity of this study. Possibly those that had attitudes that deviated from the overt or 
stated norms or that thought their answers could lead to repercussions did not participate, 
while those that thought their attitudes were accepted responded. This could mean that more 
prison health staff were less supportive of abstinence-oriented principles in OMT than what 
it appeared to be in this study (study I). The respondents’ age, gender, staff distribution and 
length of employment corresponded well to the demographics of staff in general employed 
in the organisation (Justice Health). However it is possible that those that participated 
differed from the non-participants in other variables than those measured.  
In the Norwegian staff attitudinal study (study II) all eligible OMT staff participated, 
compared to 72% of harm reduction staff. This difference was most likely due to the data 
collection procedure. The researcher was present in all except one OMT centre while 
respondents completed the questionnaires. In comparison the researcher was present in 
seven out of 12 harm reduction facilities during data collection. It was most likely easier for 
staff to complete the questionnaire when there were allocated time to complete the 
questionnaires and the researcher was present. This is possibly the main reason why the 
response rate was higher among OMT staff compared to harm reduction staff.  
Each harm reduction facility was contacted after the completion of data collection. The 
reasons given for non-participation were that some staff were not informed or lacked time to 
complete the survey. This confirms that it was easier to participate in the study when there 
were allocated time to complete the questionnaire. Additionally one person did not trust the 
questionnaire would be used as an anonymous descriptive study and therefore did not 
complete the questionnaire.  
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There was no risk of selection bias among Norwegian OMT staff as all invited staff 
participated, but there could have been some selection bias among the Norwegian harm 
reduction staff. However the reasons given for non-participation were mainly lack of 
information and/or time. There were no indications that the non-participants differed greatly 
from the participants and it is therefore not likely that selection bias have influenced the 
results in any direction. 
In the assessment of the Norwegian OMT programme (study III) there were variations 
between the regional centres in completed forms for each patient and this varied from 53% 
to 100%. Nine of 14 centres had information on more than 80% of their patients, but five 
centres lacked information on approximate 1/3 of their patients. There were no specific 
patterns in the findings that indicated a selection bias neither in the centres with the highest 
or lowest response rates; on the other hand there were no patterns that could confirm that 
there were not a selection bias and some caution in interpretation are therefore required.  
5.3 Information bias 
5.3.1 The attitudinal instrument 
The two attitudinal studies (study I and II) used an instrument that was developed in NSW, 
Australian 1996 to measure staff attitudes towards OMT (96). There exists many possible 
pitfalls of using an instrument validated in a different temporal, linguistic or cultural setting 
(7;9;121). The prison health staff study (study I) was conducted in 2003 and the Norwegian 
staff study in 2007. This means that the instrument was used in different temporal and 
cultural settings.  
The instrument was used in its’ original form in the prison health staff study (study I). It was 
assumed that the concept of abstinence-orientation in OMT was familiar to prison health 
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staff in NSW, as a previous study had found that prison health staff in the same setting had 
discouraged inmates from entering or remaining in methadone treatment (1). Confirmatory 
analysis confirmed the abstinence-orientation scales structural validity. However it is 
possible that if a cross-cultural adaptation process had been conducted other attitudes then 
those measured would have been detected. 
In the Norwegian staff study (study II) the instrument was cross-culturally adapted. In this 
thesis and in paper II the findings from the cross-cultural adaptation process were presented 
in the results section and not in the methodology section. The reason for this was that one of 
the aims in study II was to cross-culturally adapt the instrument; findings from the cross-
cultural adaptation process were therefore not solely methodological descriptions but also 
results. 
As part of the cross-cultural adaptation process in the Norwegian staff study (study II) harm 
reduction staff were included as a comparison group to OMT staff. It was expected that 
harm reduction staff would differ from OMT staff especially in terms of attitudes towards 
OMT and knowledge around methadone. It was expected that harm reduction staff would 
know less of risks and benefits of methadone compared to OMT staff as they did not work 
directly with OMT. In addition it was assumed that they would favour principles of harm 
reduction as they were employed in harm reduction facilities. The study (study II) 
confirmed that harm reduction staff differed from OMT staff in knowledge and attitudinal 
scores. Importantly multigroup analysis confirmed differences between groups in all 
parameters within the new attitudinal scale. This means that the instrument appeared to 
detect the expected differences between Norwegian OMT and harm reduction staff and thus 
had good face validity.  
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5.3.2 The instrument used in the assessment of the OMT programme 
The assessment of the OMT programme (study III) used data from the annual assessments 
of the Norwegian OMT programme in 2007 and 2008. One of the limitations of the annual 
assessments were that the instrument not necessarily was completed in collaboration with 
the patient. It should primarily be completed by the patients’ case manager either at the 
OMT centre or at social welfare services and it is expected that the person who complete the 
instrument knows the patients’ situation well. It would have strengthened the findings if all 
forms were completed in collaboration with the patients. On the other hand it is possible that 
such a requirement could reduce participation rates. The questionnaire’s inter-rater 
reliability was assessed in 2004 (140), and this study (study III) only used variables that had 
a high inter-rater reliability (>0.60). There was one exception; opioid use previous four 
weeks which had a Cohen’s kappa (k) of 0.47. However the main findings in both paper III 
and IV were based on outcomes in non-opioid drug use and social rehabilitation. This means 
that although the opioid use variable may have had a low reliability, this was not likely to 
alter the main findings and conclusions made from these findings.  
5.3.3 Classifications and labelling 
Findings from the Norwegian attitudinal study (study II) and the assessment of the OMT 
programme in 2007 (study III) were merged to assess if staff attitudes were associated with 
treatment organisation, clinical practices and outcomes (aims IV, paper IV). Centres were 
divided into three groups based upon the centres mean attitudinal scores (4-5-4). There were 
differences in mean attitudinal scores between centres, it was therefore possible to divide 
the centres’ into high and low scores groups. To reduce some of the measurement error it 
was decided to divide the centres into three equal groups. The rational for this was to ensure 
the comparison between the centres with highest and lowest mean scores.  
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5.3.4 Data analysis 
In the assessment of the OMT programme (study III) only aggregated information was 
available. This prevented detailed analysis of outcomes for individual patients and limited 
the analysis of associations between treatment characteristics, practices and outcomes.  
In the two attitudinal studies (study I and II) sum scores were from a five-point Likert scale. 
The use of data from Likert-scales in maximum likelihood analysis is a contentious issue 
(146). The controversies evolve around the treatment of ordinal scale variables as if they 
were of a continuous scale (163). Yet research has shown that with five or more response 
categories and a normal distribution, the problems from disregarding the categorical nature 
of responses are minimized (146;148;164-168). In both studies (study I and II) data were 
collected from a five-point Likert scale and had a normal distribution. It was therefore 
assumed appropriate to treat these data as continuous variables.   
5.4 Confounding 
Confounding is when the effect in focus is confused or mixed with the effects of other 
variables (158;161). It is possible to reduce the effects of confounding through stratification 
and multivariate data analysis (158;161). In the three studies included in this thesis; prison 
health staff study, Norwegian staff study and the assessment of the Norwegian OMT 
programme, multivariate data analysis were applied. However there are always the 
possibility that other variables than those assessed and analysed are associated with the 
dependent variables. 
The Norwegian OMT programme relies on the collaboration with GPs and social welfare 
services. In some regions this collaboration may be efficient and unproblematic, whereas in 
others there may be a strained relationship between the collaborating parties. Also social 
welfare services may be better equipped in some regions compared to others and as a result 
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the OMT programme achieve better outcomes in terms of social rehabilitation. 
Consequently the shared care between the OMT centre, GP and social welfare services 
could be a confounding factor in the third study (paper III and IV). Possibly the results were 
influenced by local social welfare services and the time and interests of the collaborating 
GPs. If this is the case it may be that the findings presented in paper III are not only due to 
the regional OMT centres, but also an effect of the efforts (or lack of efforts) of social 
services and/or the collaborating GP. 
5.5 Strengths  
The three studies included in this thesis had several strengths. The prison health staff study 
was the first study to investigate prison health staff attitudes towards abstinence-orientation 
in methadone treatment. The study confirmed previous findings that the support of 
principles of abstinence-orientation in methadone treatment were associated with less 
knowledge of methadone and experience with community methadone programmes. It also 
highlighted areas where improvements could be made through training and education. 
The Norwegian staff attitudinal study (study II) had a high response rate, which included all 
eligible OMT staff. This supported the validity of the findings, as it was not only a selection 
of OMT staff that responded. The instrument that was used underwent a thorough and 
appropriate cross-cultural adaptation from Australian-English into Norwegian. The cross-
cultural adaptation process was a strength of the Norwegian staff study.  
The third study (study III) was a large nationwide cross-sectional study, which included data 
from all regional OMT centres representing all Norwegian OMT patients. This gave a 
nationwide picture of OMT delivery and challenges within the Norwegian OMT 
programme. The combination of findings from the Norwegian staff study (study II) with the 
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findings from the OMT programme assessment in 2007 (study III) gave the opportunity to 
assess the association between staff attitude and treatment organisation, practices and 
outcomes between all the OMT centres (paper IV). This combination (paper IV) found that 
centres where staff were more likely to support disciplinary discharge from treatment due to 
drug use and limitations on intake criteria had smaller caseloads, more frequent urine drug 
screening and increased case management. In addition these centres had less drug use and 
more social rehabilitation among their patients. 
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5.6 External validity 
External validity requires internal validity (161). In this thesis it was possible to identify 
associations between experience and level of knowledge of methadone and support of the 
principles of abstinence-orientation (study I). It was also possible to identify associations 
between staff attitudes and treatment characteristics, practices and outcomes (study II and 
III). Additionally study III found an association between level of drug use and social 
rehabilitation in the OMT centres, these associations seemed relatively robust as the overall 
impression from these studies were that there were no major known mechanisms of 
selection bias or confounding occurring. 
In the Australian prison health staff (study I) staff were likely to support abstinence-oriented 
principles in OMT and disapprove of drug use. This was in conjunction with another study 
that found that prison health staff discouraged inmates from participation in a methadone 
trial (1). It is therefore likely that the findings from study I may be generalised to those 
Australian prison health staff that did not participate in this study. 
The assessment of the OMT programme (study III) included data from all regional centres 
representing all Norwegian OMT patients. It was therefore possible to make inference to all 
patients within the Norwegian OMT programme. Generalisations outside of the studied 
population should always be made with some caution (158). OMT is provided in many 
different manners (40) and it is therefore important to be cautious of making inference from 
the findings from the Norwegian OMT programme to OMT programmes outside of 
Norway.  
The cross-cultural adaption process in study II highlighted the importance of not assuming 
that instruments developed in one setting are valid in another. The findings from the cross-
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cultural adaptation process also indicated that attitudes found among staff in Norway in 
2007 not necessary are valid in a different time or cultural context. However the 
combination of findings from the staff attitudinal study (study II) and the assessment of the 
Norwegian OMT programme (study III) confirmed previous findings in other international 
studies (97;98;111;112;169;170); that there was an association between staff attitudes and 
treatment practices. This suggests that it is possible to make a generalisation that staff 
attitudes are associated with treatment practices also in other treatment programmes outside 
the Norwegian OMT programme.  
 
 
 
 
66 
 
6. Discussion of results 
This section discusses the main findings of this thesis and issues connecting the individual 
papers together.  
6.1 Attitudes towards and knowledge of OMT  
In the Australian prison health staff study (study I) staff that had less knowledge of risks and 
benefits of methadone and that had no experience from community OMT programmes 
tended to be more supportive of abstinence-orientation in OMT. This is in conjunction with 
previous studies that have measured attitudes towards abstinence-orientation in methadone 
treatment. Younger staff with less knowledge of methadone, less education and experience 
from the addiction field have been more likely to support abstinence-oriented principles in 
methadone treatment (99;101;103;106). This suggest that level of knowledge, educational 
level and experience are associated with attitudes towards abstinence-oriented principles in 
methadone treatment.  
It is not only in studies that have measured attitudes towards abstinence-orientation that staff 
attitudes have been associated with knowledge, experience in the field and level of 
education. Increased knowledge in regards to specific issues, such as buprenorphine, 
naltrexone, harm reduction and aggression minimization have been found to increase 
favourable attitudes towards these issues (108;110;171-173). The Norwegian staff study 
differed from other attitudinal studies as there were no associations between the measured 
attitudes and knowledge of methadone or experience in the addiction field. However the 
majority of OMT staff had high level of knowledge of methadone and long experience in 
the addiction field, this means there were only a small difference between staff in terms of 
these factors. This was possibly the reason why there was no association between 
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Norwegian attitudinal scores and knowledge of methadone or experience in the addiction 
field. Instead it is likely that other variables not measured in this study (study II) were 
associated with the attitudes. 
6.2 The cross-cultural adaptation process 
The findings from the cross-cultural adaptation process are presented as results in this thesis 
and in paper II and are therefore discussed in this section rather than in the “Methodological 
considerations” section. Since the Norwegian staff study was conducted in a different 
country, language and time from when the original instrument was developed it was cross-
culturally adapted. The original attitudinal scales were not valid in Norway. There are many 
reasons for this. It may be that the failure of the original scale in the new setting was due to 
changes in society over time (121). The original “abstinence-orientation” scale was 
developed in the 1990’s. Abstinence-oriented treatment in OMT have, since then, been 
found to be less effective than long-term maintenance (174;175). Based upon previous 
research it may be that the debate has moved on to other issues.  
On the other hand it could also be that there was a difference in the cultural context between 
the population the instrument was developed in (Australian community methadone staff) 
and Norwegian staff. At the time the original instrument was developed abstinence-oriented 
methadone treatment was common in Australia (41;54) and this was therefore an issue 
Australian community methadone staff were familiar with. In comparison abstinence-
oriented methadone treatment are not common in Norway and this type of treatment have 
never been available through the national Norwegian OMT programme. It is possible that 
Norwegian staff were unfamiliar with the principles of abstinence-orientation in OMT 
because this type of treatment is not available in the Norwegian OMT programme. 
68 
 
Regardless of reasons why the original attitudinal scales were not valid in the Norwegian 
setting, the cross-cultural adaptation process highlighted the importance of such a process. 
Previous research (7-10;123) and study II show the dangers of taking an instrument into use 
in a new setting without adjustments. If the original instrument had been taken into use in 
the Norwegian staff study without the cross-cultural adaptation process, the findings would 
have been misleading, even if presented with apparent precision.  
6.3 Treatment differences in the Norwegian OMT programme 
The assessment of the Norwegian OMT programme found differences between the 14 
regional OMT centres in treatment characteristics, patients’ drug use and social 
rehabilitation. Centres with high use of drugs had lower levels of social rehabilitation 
among their patients. Diversity in treatment organisation, practices and outcomes are 
common (40). There may be differences in type of agonist such as buprenorphine or 
methadone, in the use of intake and discharge criteria as well as caseload and services 
available to patients (40;42;49). These differences may be found both between and within 
countries (40;49;176). Yet this study (study III) was conducted within a national OMT 
programme, comparing 14 regional OMT centres that were subject to the same government 
treatment standards, and not between independent treatment programmes. The data show 
that centres organised treatment differently and that patients did not achieve similar 
outcomes.  
One reason why centres organised their treatment differently could be that current treatment 
guidelines conflicted with what staff interpreted as evidence-based treatment practices. 
There were no regulatory body that ensured adherence to a minimum of treatment standards, 
except that patients may file a complaint to their regional board of supervision. This could 
be another reason why there were differences in treatment provision. A third reason could 
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be that there were not enough resources to adhere to the government treatment standards at 
least in some centres.  
However it was not only differences in treatment provision, it was also a difference between 
centres in treatment outcomes; where centres that had high levels of drug use had lower 
levels of social rehabilitation. One of the reasons for variations in treatment outcomes could 
be differences in patient populations. Another reason could be differences in the quality of 
treatment provided. Data from 2006 and 2007 were analysed and the same differences 
between centres were found. As in 2008 there was no difference between centres in patients’ 
age and gender distribution. In addition the regulations specify that only those with long-
term opioid dependence should be accepted into treatment. It is therefore unlikely that the 
patients’ characteristics alone i.e. severity of dependence and drug use patterns, could 
explain all the observed variations. Instead other factors not assessed in this study may have 
influenced treatment outcomes, such as differences in staff attitudes and organisational 
culture. 
6.4 Staff attitudes and the associations with treatment differences 
There was an association between staff attitudes and treatment differences (paper IV). OMT 
centres where staff were more likely to support disciplinary discharge due to drug use and 
limitations on intake criteria had smaller caseloads, more frequent urine drug screening and 
increased case management. In addition these centres had less drug use and more social 
rehabilitation among their patients. 
In 2004 key OMT staff member’s attitudes towards drug use and harm reduction were 
assessed (2). The centres were divided into three groups; “restrictive”, “liberal” and 
“neutral” based upon this assessment (2). In 2007 patients in the “liberal” centres were 
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found to have the highest frequency of benzodiazepine prescriptions (6). In the Norwegian 
staff study (study II) the “harm reduction-oriented” centres had the most non-opioid drug 
use, which is consistent with the findings from the latter study (6).  
Not only type of attitudes, but also staff consensus has been associated with treatment 
practices and outcomes (120;177;178). In one study, treatment programmes with higher 
mean attitudinal scores (stronger attitudes) had less variability in their scores (179). Less 
variability in attitudinal scores means that there was more consensus between staff in terms 
of attitudes towards treatment. These treatment programmes had better treatment outcomes 
compared to other programmes (179). This suggests that treatment programmes where staff 
have strong attitudes towards a treatment issue will have higher consensus between them. 
Possibly high staff consensus means that their treatment practices are more coordinated and 
that they agree on treatment goals. As a consequence they achieve better treatment 
outcomes compared to treatment programmes where staff attitudes are not so strong. 
In the Norwegian OMT programme (study II) there were differences in the mean attitudinal 
scores between the regional centres. The scores between centres ranged from 2.5 to 4.3. The 
theoretical score range was 1 to 5. Centres that had a mean score of 4 and more were closer 
to the highest end of the theoretical scale, and thereby had the strongest attitudes. By 
comparison centres with the lowest scores had mean scores around 2.5 which were in the 
middle of the theoretical scale. The centres with the highest attitudinal scores 
(“rehabilitation-oriented”) in paper IV had lower levels of drug use and higher levels of 
social rehabilitation compared to the other centres. Possibly these centres had better 
treatment outcomes as a consequence of higher staff consensus and agreement on treatment 
goals. 
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Differences in attitudes towards OMT and the associations with treatment could be a result 
of an organisational culture. The initiation of the Norwegian OMT programme were 
influenced by strong forces that opposed methadone treatment, those that believed that 
OMT should only be provided to a selected few and those that believed OMT should be 
available to all opioid dependents (36-38;180). The findings from the Norwegian staff study 
(study II) suggests that these attitudinal differences towards OMT still exist within the 
Norwegian OMT programme and that the attitudes and treatment practices (organisational 
culture) have developed somewhat differently within the different centres. 
A large proportion (63%) of Norwegian OMT staff (study II) had worked in the addiction 
field for more than six years. This means that many had worked in the addiction field when 
OMT was introduced in Norway and it is likely that this have influenced their attitudes 
towards OMT and treatment practices. When new staff begin their working career at an 
OMT centre it is likely that they are influenced by the attitudes and subsequently treatment 
practices of those that have more experience in the addiction field. In this manner specific 
organisational cultures develop and are maintained in each centre.  
One of the main strategies to reduce treatment differences between treatment programmes is 
to develop treatment guidelines (181;182). Ideally guidelines should ensure that the aims of 
treatment and how it should be provided are clearly stated and easy to follow (181;182). 
Nonadherence to guidelines is common especially if the guidelines are only advisory and 
there are no consequences for nonadherence (183). Staff attitudes and organisational culture 
are identified as one of the obstacles in terms of guideline adherence (120;184). Staff 
attitudes are likely to influence adherence especially if there exist contradictory evidence in 
the field on what is best practice (182). Contradictory or limited evidence for treatment 
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practices are common in the addiction field (13;19;28;30;185). To introduce treatment 
guidelines in the addiction field with the aim of reducing treatment differences will 
therefore be a challenge because of the existence of contradictory and limited evidence in 
the field.  
In 2010 new OMT guidelines and regulations were introduced by the Norwegian 
Directorate of Health (186). One of the aims of these guidelines was to reduce treatment 
differences between centres (134). However it is yet to be known whether the introduction 
of these guidelines is sufficient to address the differences in staff attitudes which are likely 
to be embedded into a organisational culture. It is also uncertain whether treatment 
differences will be reduced or not.  
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7. Future research 
The three studies included in this thesis (prison health staff study, Norwegian staff study, 
OMT programme assessment) all had cross-sectional designs. The cross-sectional design 
prevents inference made to causality. Future research should attempt to use individual 
patient information to further assess associations between treatment organisation, practices 
and outcomes. 
The Norwegian staff study (study II) found marked variations in staff attitudes between the 
regional centres within the Norwegian OMT programme. These variations were associated 
with measurable differences in caseload, case management and patient outcomes. In 
addition centres that had increased drug use (benzodiazepines, central stimulants, cannabis), 
had less social rehabilitation among their patients, but it was not possible to detect any 
associations between specific treatment organisation, practices and outcomes. The lack of 
associations was possibly due to the use of aggregated information. Future research should 
therefore use individual information to further explore the associations between treatment 
provided and outcomes. 
In 2010 new OMT guidelines were introduced in Norway (134). One of the aims of these 
guidelines was to reduce treatment differences between the regional OMT centres. Thus it is 
essential to assess if the differences persist despite the new guidelines and to assess if there 
continue to be an association between staff attitudes and treatment organisation, practices 
and outcomes. The annual assessments of the Norwegian OMT programme collect the same 
information from all Norwegian OMT patients each year. This gives the opportunity to 
assess changes in treatment over time. However currently these data are only available as 
aggregated data, with individual patient information it would be more likely to find 
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associations between specific treatment organisation, practices and outcomes. Currently we 
know that there are differences between the regional OMT centres in staff attitudes and that 
there is an association with treatment provided and outcomes. Future research should 
explore these differences and associations further using individual information. Importantly 
future OMT programme research should include measures on staff attitudes towards OMT, 
as they seem to be an important factor associated with treatment organisation, practices and 
subsequently treatment outcomes in OMT.  
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8. Conclusions 
This thesis investigated attitudes towards and knowledge of OMT in three different 
populations; prison health staff in NSW, Australia, Norwegian OMT staff and harm 
reduction staff in Oslo. The cross-cultural adaptation process highlighted the dangers in 
taking an instrument into use in a new setting without adjusting the instrument. If the 
original instrument had been taken into use in the Norwegian staff study without the cross-
cultural adaptation process, the findings would have been misleading, even if presented with 
apparent precision. This means that the use of all research instruments including those that 
are assumed to be standardised requires caution if the instrument was developed in a 
different language, setting or time. It will always be a balance between retaining an 
instruments original terminology and words and to ensure that the terminology and words 
make sense in the new setting.   
Positive attitudes towards abstinence-orientated principles in methadone treatment, among 
Australian prison health staff, were associated with less knowledge around risks and 
benefits of methadone and less experience with methadone treatment in the community. In 
comparison attitudes towards disciplinary discharge due to drug use and limitations on 
intake criteria were not associated with knowledge as measured in the Norwegian study or 
experience among Norwegian OMT and harm reduction staff.  
The assessment of the Norwegian OMT programme identified variations in treatment 
organisation, practices and outcomes between the regional OMT centres. These variations 
were associated with Norwegian OMT staff attitudes towards OMT. These findings suggest 
that there exist different organisational cultures including staff attitudes within the 
Norwegian OMT programme that influence treatment outcomes. This means that attitudes 
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play an important role in the Norwegian OMT programme and it is important for staff, 
managers and stakeholders to be aware of this. To become aware of what attitudes exist 
within ones centres is one step towards ensuring that treatment is not ruled solely by 
attitudes. Another step would be to introduce OMT guidelines. Such guidelines were 
introduced in 2010; however is it yet to be known whether these will reduce differences in 
staff attitudes and treatment. This thesis provide baseline information for future follow up 
studies to measure changes in staff attitudes and the associations with treatment 
organisation, practices and outcomes after the introduction of new guidelines and 
regulations. Additionally the findings from this thesis suggest that future OMT programme 
assessments should include measures of staff attitudes as it is an important factor in OMT. 
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Abstract
Background: Research questionnaires are not always translated appropriately before they are used in new
temporal, cultural or linguistic settings. The results based on such instruments may therefore not accurately reflect
what they are supposed to measure. This paper aims to illustrate the process and required steps involved in the
cross-cultural adaptation of a research instrument using the adaptation process of an attitudinal instrument as an
example.
Methods: A questionnaire was needed for the implementation of a study in Norway 2007. There was no
appropriate instruments available in Norwegian, thus an Australian-English instrument was cross-culturally adapted.
Results: The adaptation process included investigation of conceptual and item equivalence. Two forward and two
back-translations were synthesized and compared by an expert committee. Thereafter the instrument was
pretested and adjusted accordingly. The final questionnaire was administered to opioid maintenance treatment
staff (n=140) and harm reduction staff (n=180). The overall response rate was 84%. The original instrument failed
confirmatory analysis. Instead a new two-factor scale was identified and found valid in the new setting.
Conclusions: The failure of the original scale highlights the importance of adapting instruments to current
research settings. It also emphasizes the importance of ensuring that concepts within an instrument are equal
between the original and target language, time and context. If the described stages in the cross-cultural
adaptation process had been omitted, the findings would have been misleading, even if presented with apparent
precision. Thus, it is important to consider possible barriers when making a direct comparison between different
nations, cultures and times.
Background
There is much emphasis on using standardized and vali-
dated research instruments [1]. One reason for this is
the assumption that it enables comparisons of results
across different studies both nationally and internation-
ally [1]. Another assumption is that the use of validated
instruments increases the certainty with which the
instruments accurately reflect what they are supposed to
measure [1]. However, a previously validated instrument
does not necessarily mean it is valid in another time,
culture or context [2-5].
There is no universal agreement on how to adapt an
instrument for use in another cultural setting. However,
there is agreement that it is inappropriate to simply
translate and use a questionnaire in another linguistic
context [2,6]. Conversely, studies may have a compre-
hensive linguistic translation process, but this still does
not ensure construct validity and reliability [4,5]. As an
example a questionnaire that asks about physical activity
and uses cross-country skiing as an example may not be
relevant in settings where there is no snow [2]. More-
over, a depression inventory validated in addicted indivi-
duals is likely to confuse somatic symptoms of
depression with those of intoxication and withdrawal.
Additionally, instruments that were validated some time
ago may not be valid in the present time due to changes
in society that occur continuously [2,3].
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In Norway an instrument that measured staff attitudes
towards opioid maintenance treatment (OMT) was
needed for a study. Staff attitudes towards OMT had
never previously been investigated in Norway; conse-
quently there were no instruments available in Norwe-
gian. An Australian-English instrument that measured
staff attitudes towards OMT was available. The instru-
ment was developed in NSW, Australia, in 1996 [7].
The instrument had been used in several other studies
in Australia [8-11], USA [12-15], Netherlands [16], Ger-
many [17], and Spain [18]. Items tailored towards the
country’s OMT system were added when the instrument
was used outside of Australia [12-18]. However, pre-
vious research had not explicitly addressed the cross-
cultural adaptation process of the questionnaire.
The cross-cultural adaptation process is important
when an instrument is used in a different language, set-
ting and time to reduce the risk of introducing bias into
a study [2]. In addition attitudes cannot be measured
directly [19]. This means that attitudes are measured
indirectly, through some set of items in a questionnaire
[19]. In studies where a phenomenon is measured indir-
ectly with questionnaires, comparison of results between
cultures and groups may be a challenge. In particular
comparison will be difficult if the adaptation process has
been flawed. It is therefore important that each item is
adapted appropriately.
Thus the aim of this paper is to illustrate the process
and required steps involved in the cross-cultural adapta-
tion of a research instrument using the adaptation pro-
cess of an attitudinal instrument as an example.
Methods
A suggested cross-cultural adaption process
Table 1 shows a suggested sequence of the cross-cul-
tural adaptation process. The first stage is to assess if
there is the same relationship between the questionnaire
and underlying concept in both the original and target
setting [2,3]. In addition it is important to assess that
items within the instrument are equally relevant and
acceptable in the target population as they are in the
original population [2]. Both conceptual and item
equivalence can be assessed through a literature review
[2,3]. Findings from the literature review should be dis-
cussed with experts in the field and members of the tar-
get population [2,3].
The original instrument should thereafter be trans-
lated from the original language into the language of the
target population [2-5]. At least two persons should pro-
duce the initial translations independently [4-6]. The
translators should be fluent in the language of the target
population with a good understanding of the original
language [2-5]. The translated versions should be
synthesized into one version by a third independent
translator [4,5]. Thereafter the synthesized version
should be back-translated independently by at least two
different persons [4-6]. The back-translators should be
fluent in the original language with a good understand-
ing of the language in the target population [2-5].
Thereafter the synthesized translated version and the
synthesized back-translated version should be reviewed
by an expert committee [4,5].
The expert committee should comprise of methodolo-
gists, health professionals, language professionals, and
the translators (forward and back-translators) [4]. The
expert committee assesses if a word or several words
reflect the same ideas or subjects in both the original
and adapted versions of the questionnaire [2-5]. This
assessment ensures that items are translated correctly
and are relevant in the new setting [4-6]. If there are
uncertainties around the meaning of specific words or
items, the developer of the original instrument can be
contacted for clarifications [2,4]. It is also suggested to
return to the target population and have experts in the
field discuss subtleties brought out by the various trans-
lation proposals [3]. The instrument should be adjusted
accordingly after a consensus is reached [4,5].
Table 1 A suggested cross-cultural adaptation process
Investigation of conceptual
and item equivalence
Literature review
Discussion with experts in the field and
members of target population
Original instrument
translated
Translator I:
Fluent in target language, good
understanding of original language
Translator II:
Fluent in target language, good
understanding of original language
A synthesized translated
version
Translator III:
Fluent in target language, good
understanding of original language
Back-translations Back-translator I:
Fluent in original language, good
understanding of target language
Back-translator II:
Fluent in original language, good
understanding of target language
A synthesized back-
translated version
Back-translator III:
Fluent in original language, good
understanding of target language
Expert committee
Instrument pretested
Revised instrument
Investigation of operational
equivalence
Literature review
Discussions with experts in the field and
members of target population
Main study
Exploratory and confirmatory
analysis
Final instrument
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Thereafter the instrument should be pretested [4].
Between 30 and 40 respondents are viewed as appropriate
in the pretest [3,4]. Respondents are probed for their
understanding, acceptability and emotional impact of the
items in order to detect confusing or misleading items
[3,4]. To ask respondents to rephrase each item is one
technique that can identify whether an item is understood
or not [3]. Reichenheim (2007) suggests that interviews
are conducted until a pre-established percentage of under-
standing is achieved for all items (e.g. ≥ 90%) [3]. A final
semantic adjustment should be made by the research
group based on the evidence from the pilot study [3-5].
The operational equivalence of the instrument should
be evaluated after the semantic adjustments [2,3]. Opera-
tional equivalence means that it is possible to use similar
questionnaire format, instructions, mode of administra-
tion and measurement methods in the target populations
as was used in the original setting [2]. A literature review
may give information regarding the use of instruments in
the target setting [2]. It is also possible to contact experts
in the field and members of the target population to
assess if format, instructions, mode and administration
and measurement methods are appropriate [2]. Once
consensus is reached in regards to operational equiva-
lence, the methods are incorporated into the study [3].
Finally, the instrument should be administered to par-
ticipants in a formal study. On the basis of the results
from this study the psychometric properties of the
instrument should be tested using recognized statistical
methods [4,5].
Study instrument
The original study instrument was developed in 1996
[7]. The instrument comprised two attitudinal scales.
The 14-item “Abstinence-orientation” scale contained
two almost perfectly correlated dimensions: attitudes
towards abstinence-oriented policies and support for
disciplinary actions if programme rules were broken [7].
Cronbach’s alpha for the “Abstinence-orientation” scale
was a = 0.89 [7]. The “Disapproval of Drug Use” scale
comprised six-items and was characterised by state-
ments such as “modern society is too tolerant towards
drug addicts”, “marijuana should be legalized”, “drug
addiction is a vice” and “drug addiction is a menace to
society” [7]. The Cronbach’s a was 0.75. There was a
positive correlation between the “Abstinence-orienta-
tion” and “Disapproval of Drug use” scales (r = 0.64) [7].
The responses were answered on a five-point Likert
scale ranging from “strongly disagree = 1” to “strongly
agree = 5” [7]. A sum score was calculated for each of
the two attitudinal scales by dividing the number of
completed items by the total score [7].
Additionally the instrument comprised of a 12-item
knowledge scale. This scale tested respondents’
knowledge of the benefits and risks of methadone treat-
ment [7]. The scale was characterised by statements
such as “methadone, when given as a maintenance pro-
gramme, reduces ("blocks”) the effects of heroin” and
“methadone maintenance reduces addicts’ criminal
activities” [7]. The items were scored “1” for correct
answer, “0” for “uncertain” and “-1” for incorrect answer
[7].
In total there were 32 items in the original instrument.
The attitudinal and knowledge items were mixed
throughout the instrument [7].
Main study
The study had a cross-sectional multicenter design. Staff
(n=140) from the national OMT programme and harm
reduction services (n=180) in Oslo were invited to partici-
pate. The national OMT programme comprised of 14 cen-
tres and employed from three to thirty-three staff
members. In this study two of the 14 centres were merged
because they had a joint staff group at the time of the
study. Harm reduction services included street clinics,
needle-exchange programs, injecting rooms and housing
facilities. The harm reduction services included 12 facil-
ities and employed between six to thirty employees.
Data was collected between August and November of
2007 and was mainly collected through visits by the first
author. The researcher was present during the comple-
tion of the questionnaires in all except one OMT centre
and five harm reduction facilities. In the one OMT cen-
tre the researcher gave information during a staff meet-
ing and questionnaires were returned by mail. In one
harm reduction facility information about the study was
given only to the leader of the facility. Questionnaires
from this facility were returned by postal mail. In four
harm reduction facilities the researcher gave information
during staff meetings and questionnaires were returned
by email and mail. Follow-up phone calls were made to
ensure that staff returned questionnaires.
The study was approved by the Norwegian Regional
Ethics Committee and the Data Inspectorate. Partici-
pants received written and oral information about the
study. Respondents consented to participate in the study
by submitting the questionnaire. The questionnaire was
semi-anonymous. This means names were not required,
but the name of the facility and other demographic vari-
ables made some staff theoretically identifiable. Partici-
pants were promised full anonymity. Demographic
variables that identify respondents will therefore be
deleted upon completion of the project.
Data analysis
Descriptive statistics were calculated using the statistical
software SPSS version 16.0 [20]. Data were assessed
using exploratory and confirmatory statistical analysis.
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Initially the 14 original abstinence-oriented items were
tested through confirmatory analysis. The confirmatory
analyses were based on the one-factor model developed
by Caplehorn, Irwig and Saunders [7]. Subsequently
both original and new items were assessed using
exploratory factor analysis. The model retrieved through
exploratory factor analysis was tested through confirma-
tory analysis. Exploratory factor analyses were com-
pleted in the statistical software SPSS version 16.0 [20].
Confirmatory analyses were completed in the statistical
software AMOS graphic version 17.0 [21].
Exploratory factor analyses were completed using
principal axis and oblique rotation methods (promax).
The correlation matrix and factor loadings were used to
decide which items to retain. A scree plot was used to
decide the number of factors to retain. Additionally the
Cronbach’s alpha was assessed.
Confirmatory analyses were completed through struc-
tural equation modelling using maximum likelihood
analysis. Data were checked for normality both graphi-
cally and by assessing univariate and multivariate skew-
ness and kurtosis.
The statistical software AMOS version 17.0 does not
handle missing values when modification indices are
estimated [21]. Thus a missing value pattern was gener-
ated for all items to ensure that values were missing at
random. If values were missing at random it would be
appropriate to delete missing values listwise for the con-
firmatory analysis.
The sample data included two different groups (harm
reduction staff and OMT staff), thus multigroup ana-
lyses were applied. Multigroup analyses were com-
pleted stepwise. The steps were 1) the model was
tested separately in each group, 2) equal form (uncon-
strained model) was assessed, 3) equality of factor
loadings were tested, 4) equality of structural covar-
iances and 5) equality of measurement errors were
assessed. Thereafter if factor loadings and indicator
intercepts were invariant, the equality of latent means
was assessed [22-24].
There are several goodness-of-fit indices available in
maximum likelihood analysis and no agreement on
which are best. Goodness-of-fit indices reflect different
aspects of the model. It is recommended to report sev-
eral fit indices to assess how well the hypothetical
model fit the sample data [23]. In this study the decision
of overall model fit was based upon four fit indices.
These indices were the comparative fit index (CFI) [25],
the Tucker-Lewis index (TLI) [26] and the root mean
square error of approximation (RMSEA) [27]. The aver-
age variance extracted (AVE) [28] was also assessed.
Aikaike’s information criterion (AIC) [29] and the
Browne-Cudek criterion (BCC) [30] were assessed to
decide best model fit in the multigroup analysis. The
standardized residuals and the modification indices were
assessed to identify any areas of misfit in the model [31].
CFI is based on a comparison of a hypothesized model
and a baseline model [25]. The advantage of this fit index
is that it avoids underestimation of fit as it takes sample
size into account [23,25]. TLI also addresses the issues of
wrongful rejection or acceptance of a model due to sample
size [23,26]. Values for both CFI and TLI range from zero
to 1.00. Values above 0.90 indicate acceptable fit, whereas
values close to 0.95 are indicative of good fit [32].
RMSEA is an attempt to correct for the tendency of
the chi-square statistic to reject models with a large n
or a large number of observed variables [27]. One of the
main advantages of RMSEA is that a confidence interval
(CI) can be constructed [31]. Values less than 0.05 indi-
cate good fit and values as high as 0.08 represent rea-
sonable errors of approximation in the population
[23,24]. Values ranging from 0.08 to 0.10 indicate med-
iocre fit, and those greater than 0.10 indicate poor fit
[23,24].
AVE is a summary indicator of convergence [28]. An
AVE of at least 0.50 means that variance explained by
the construct is greater than the measurement error
[28,31]. AIC and BCC indicate the best trade-off of
model fit and parsimony in multigroup analysis
[23,29,30]. The model with the smallest estimate indi-
cates the best fit [23].
Results
Investigation of conceptual and item equivalence
The research team identified four main concepts within
the study instrument. The identified concepts were 1)
abstinence-orientated policies in methadone treatment,
2) attitudes towards disciplinary actions if programme
rules were broken, 3) attitudes towards drug use in gen-
eral and 4) knowledge of risks and benefits of metha-
done treatment. These concepts were identified through
reading previous papers that had used the study instru-
ment. In addition each item within the instrument was
assessed for potentially irrelevant concepts in the target
population.
After a review of the literature, experts and members
of the target population were consulted. Based upon the
literature review and the general feedback it was decided
to omit the six items that made up the “Disapproval of
drug use” scale. There were doubts around the relevance
of the abstinence-oriented items, but it was decided to
retain these items. All other items were retained except
for one knowledge item that the scale’s original develo-
per suggested be omitted.
Additional items
It became evident that the instrument lacked certain
concepts relevant in the Norwegian setting through
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discussions and feedback from experts in the addiction
field and OMT staff. The main aim of the Norwegian
attitudinal study was to identify attitudes that were rele-
vant in the Norwegian setting. Thus it was decided to
add items to the instrument. OMT staff and experts in
the field were asked to suggest additional items. These
suggestions came both via email and in face-to-face
meetings. Based upon a subjective judgment of the
authors and the feedback from the experts in the field,
12 attitudinal statements were added to the instrument.
Examples of these statements are found in italics in
table 2. Some items were variants of the original items,
while other items introduced new concepts. The addi-
tional items were placed after the original items and
thus did not alter the instrument’s original structure.
Forward and back-translations
The original version of the questionnaire was translated
from Australian-English to Norwegian by two transla-
tors. One of the translators was a health professional
and the other translator was not. Both translators were
fluent in Norwegian and had good knowledge of Eng-
lish. A third person reviewed the two translated versions
and synthesized the two versions into one. This third
person was fluent both in Norwegian and English. Both
translators agreed on the synthesized version.
Next, the synthesized version was back-translated by
two different people. One person was a health profes-
sional and one was not. One of the back-translators had
English as native language, whereas the other person
had lived and studied in the US for many years. The
same person, who synthesized the translated versions,
reviewed the two back-translations. The two back-trans-
lated versions were then synthesized into one. Words
that were back-translated differently were highlighted
and discussed. When an agreement was reached, the
word was added to the synthesized version.
Review by expert committee
Finally the original instrument, the translated version
and the back-translated version were compared by a
committee. The committee comprised of PhD students,
psychiatrists, medical doctors, one registered nurse and
OMT staff. All members of the committee had either
full-time or part-time positions at the Norwegian Centre
for Addiction Research. All members knew the Norwe-
gian OMT system well. Several members of the commit-
tee were fluent in both English and Norwegian, and had
completed their degrees in English speaking countries.
The instrument was adjusted according to advice from
the committee. None of the translators or members of
the committee were financially reimbursed.
Table 2 Factor loadings in the “Compliance” and “Accessibility” scale
OMT staff Harm reduction staff
Compliance items Factor
loading
Squared multiple
correlations†
Factor
loading
Squared multiple
correlations†
OMT patients who ignore repeated warnings to stop using heroin should be
gradually withdrawn off methadone
0.630 0.397 0.729 0.532
OMT patients who continue to abuse non-opioid drugs (e.g. benzodiazepines)
should have their dose of OMT medication reduced.
0.612 0.374 0.611 0.374
If repeated warnings of non-prescriptive use of benzodiazepines are ignored, the
patient should be discharged from the OMT program
0.939 0.882 0.948 0.898
If repeated warnings of use of Cannabis are ignored, the patient should be
discharged from treatment (OMT)
0.845 0.714 0.643 0.413
The GP should waive the right to prescribe class A and B drugs other than the OMT
medication to OMT patients
0.540 0.292 0.472 0.223
OMT patients who continue to take drugs and function poorly should be
discharged from the OMT program
0.675 0.455 0.726 0.527
It is unethical to discharge patients from the OMT program due to continuing drug
use and poor functioning
0.672 0.451 0.690 0.475
Accessibility items
OMT services should be expanded so all heroin addicts who want OMT can
receive it
0.635 0.403 0.683 0.466
It is unethical to deny heroin addicts OMT 0.678 0.460 0.743 0.552
OMT’s main aim is to reduce harmful effects of opioids and IV drug use (syringes) 0.487 0.237 0.310 0.096
GPs should be able to initiate OMT-medication on their own initiative 0.288 0.083 0.385 0.148
Too many LAR-patients are discharged from the OMT program 0.475 0.226 0.379 0.143
Young opioid dependents (<20) should not be offered OMT 0.495 0.245 0.403 0.162
Examples of additional items in italics
† The extent that the variance of the measured variable is explained by the latent factor.
Gjersing et al. BMC Medical Research Methodology 2010, 10:13
http://www.biomedcentral.com/1471-2288/10/13
Page 5 of 10
Pretest of instrument
A pretest of the instrument (response rate 42/69) was
completed among staff working in the addiction field,
but not in OMT in May-June 2007. OMT staff were not
invited to participate as they were the target population
in the main study. Questionnaires were mailed out via
email and postal mail. The respondents were asked to
complete the questionnaire and comment on words and
sentences that were difficult to understand. These com-
ments were written on a paper attached to the question-
naire. There were no criteria for how to reach certain
decisions, such as retain or adjust items. Instead this
was based solely on the subjective judgement of the
researcher and group discussions with experts in the
field.
Unclear words and items identified in the pretest were
discussed with members of the expert committee and
target population. Final adjustments were made based
on the subjective judgement of the research team after
discussions with members of the expert committee and
target population.
Assessment of operational equivalence
After the final adjustments of the instrument, the instru-
ment format, instructions, mode of administration and
measurement methods were assessed by the research
group. There was nothing in the format, instructions,
mode of administration or measurement methods that
was unfamiliar to the Norwegian setting.
Main study
The overall response rate was 84% (269 out of 320 ques-
tionnaires were returned). All staff in the OMT pro-
gramme (100%), and 129 out of 180 (72%) of harm
reduction staff completed the survey.
Reasons given for non-participation in the harm
reduction facilities were that staff was not informed and
did not have time to complete the survey. One person
did not trust the questionnaire would be used only as
an anonymous descriptive study and therefore did not
complete the questionnaire. Two questionnaires (0.74%)
were unusable due to incomplete answers. There were
no specific patterns in the missing values. For the con-
firmatory analysis 21 individuals from harm reduction
and 14 individuals from OMT were deleted listwise due
to one or more missing attitudinal items.
2/3 of the respondents were women. OMT staff were
older than harm reduction staff, with the majority of
staff (60%) in the age category 40 to 59 years. All OMT
staff had more than three years of tertiary education,
whereas 43% of harm reduction staff had less than three
years of tertiary education. In addition more OMT staff
had worked more than six years in the addiction field
compared to harm reduction staff (62% versus 41%).
Confirmatory analysis of the original abstinence-oriented
scale
Data had a normal distribution. The original one-factor
abstinence-oriented scale failed confirmatory analysis.
This means that the model did not have a good-fit-to the
data neither in OMT staff (RMSEA = 0.11 (90% CI 0.09;
0.13), CFI = 0.59, TLI = 0.52, AVE = 0.17) nor in harm
reduction staff (RMSEA = 0.12 (90% CI 0.09; 0.14), CFI =
0.58, TLI = 0.51, AVE = 0.19). There was substantial cov-
ariance between measurement error 3 and 5 (MI =
19.533) and error 2 and 7 (MI = 31.554) in the OMT
group. The model was adjusted accordingly, but the
adjusted model did not have an adequate fit to the data.
In harm reduction staff, there was a relatively large covar-
iance between error 2 and 7 (MI = 23.807), error 8 and
12 (MI = 11.439) and error 13 and 14 (MI = 11.439). The
model was adjusted accordingly, but this model also
failed. Table 3 shows the original factor loadings and the
factor loadings in the current study. The Cronbach’s
alpha was a = 0.71 in harm reduction and a = 0.67 in
OMT staff. In comparison the Cronbach’s alpha was (a =
0.89) when the scale was originally developed.
Omitted items in the exploratory factor analysis
Five of the 14 original items had to be explained to
almost all respondents (items in italics in table 3).
Throughout the cross-cultural adaptation process there
had been doubts around the relevance of these items in
the Norwegian setting. Thus it was decided to omit the
five items from the following exploratory factor analysis.
Assessing original and new items using exploratory factor
analysis
The analysis produced a two-factor model including 13
items. The first factor, “Compliance”, included seven
items (a = 0.89). “Compliance” explained 44% of the
variance in the model and the eigenvalue was 5.74.
“Compliance” reflected staff attitudes towards sanctions
against continuing drug use among OMT patients. The
second factor, “accessibility”, included six items (a =
0.78) and explained 11% of the variance in the model.
Eigenvalue was 1.4. “Accessibility” reflected staff atti-
tudes towards intake criteria in OMT.
Confirmatory analysis of the model retrieved through
exploratory factor analysis
The new attitudinal model had an adequate fit to the data
in both groups (Table 4). In the OMT group the model
was adjusted to allow covariance between error 1 and 6
(MI = 11.014). The goodness-of-fit indices were improved
by this adjustment (Table 4). The model was also
improved in the harm reduction group when the model
was adjusted to allow covariance between error 6 and 7
(MI = 16.31) and error 11 and 12 (MI = 8.35) (Table 4).
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Table 3 Items and factor loadings in the original abstinence-oriented scale
Original abstinence-oriented
items
Original
factor
loadings
OMT staff Harm reduction staff
Factor loadings Squared multiple correlations† Factor loadings Squared multiple correlations†
Confrontation is necessary in
the treatment of drug addicts
0.53 0.358 0.128 0.556 0.309
Left to themselves, most
methadone patients would stay
in maintenance for life
0.60 0.007 < 0.001 0.013 < 0.001
OMT services should be
expanded so all narcotic
addicts who want OMT can
receive it
0.62 0.238 0.057 0.246 0.061
Abstinence from all opioids
(including methadone) should
be the principal goal of
maintenance treatment
0.60 0.516 0.266 0.531 0.282
Methadone maintenance
patients who continue to use
illicit opiates should have their
dose of methadone reduced
0.77 0.699 0.489 0.457 0.209
No limits should be set on the
duration of methadone
maintenance
0.64 0.260 0.067 0.514 0.265
Methadone should be gradually
withdrawn once a maintenance
patient has ceased using illicit
opiates
0.62 0.193 0.037 0.558 0.311
It is unethical to deny a
narcotic addict OMT
0.54 0.284 0.080 0.334 0.112
OMT patients who ignore
repeated warnings to stop
using illicit opiates should be
gradually withdrawn off
methadone
0.76 0.659 0.434 0.594 0.353
Maintenance patients should
only be given enough
methadone to prevent the
onset of withdrawals
0.59 0.115 0.013 0.248 0.062
The clinician should
encourage patients to remain
in methadone maintenance
for at least three to four years
0.51 0.036 0.001 -0.123 0.015
It is unethical to maintain
addicts on methadone
indefinitely
0.58 0.354 0.126 0.385 0.148
OMT patients who continue to
abuse non-opioid drugs (e.g.
benzodiazepines) should have
their dose of OMT medication
reduced.
0.60 0.602 0.363 0.530 0.281
The clinician’s principal role is
to prepare methadone
maintenance patients for drug-
free living
0.56 0.526 0.277 0.464 0.216
Items in italics omitted from exploratory analysis of a new attitudinal scale
† The extent that the variance of the measured variable is explained by the latent factor.
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Multigroup analysis showed that the attitudinal scale
differed in all parameters between the two groups
(Table 4). The mean “compliance” score for OMT staff
was 3.38 (95% 3.23; 3.52) and mean “accessibility” score
was 3.51 (95% CI 3.40; 3.62). In harm reduction mean
compliance score was 2.54 (95% CI 2.42; 2.67) and
mean “accessibility” score was 2.49 (95% CI 2.39; 2.59).
It was not possible to assess differences in latent means
between the two groups as item intercepts and factors
loadings were not equal (Table 4). Factor loadings in the
two scales are shown in table 2. There was also a differ-
ence in factor covariance between the two groups
(Table 4). In OMT staff the covariance between “com-
pliance” score and “accessibility” was 0.32 and in harm
reduction staff the covariance was 0.15. Consequently
there was also a difference in factor correlations. Factor
correlations were 0.71 for OMT staff and 0.37 for harm
reduction staff.
Additionally the two groups differed in knowledge
scores. OMT staff had a mean knowledge score of 6.19
(95% CI 5.80; 6.58). In comparison harm reduction staff
had a mean knowledge score of 3.43 (95% CI 2.92; 3.93).
Discussion
The failure of the original scale highlights the impor-
tance of adapting instruments to current research set-
tings. It also emphasizes the importance of ensuring a
single item’s and concept’s validity in the current lan-
guage, time and context. The thorough assessment of
the Australian attitudinal instrument showed that the
concept of abstinence-oriented principles in OMT was
not as relevant in the Norwegian setting as it was in
Australia in the 1990s. Importantly, if no items had
been added at the end of the original instrument, the
only findings of this study would have been that the ori-
ginal scale was not valid in Norway. Alternatively, one
could have ignored the validity testing intentionally and
simply reported findings. However, this would have
been misleading and could have given the impression
that abstinence-oriented principles in OMT was a cur-
rent and contentious issue in Norway in 2007.
There are many potential reasons why a cross-cultu-
rally adapted scale fails confirmatory analysis. One rea-
son could be a flawed cross-cultural adaption process.
This introduces the possibility that the instrument does
not measure the same concepts in the original and tar-
get settings. The pretest was not conducted according
to suggested guidelines [2-5]. Instead respondents were
asked to highlight problematic words or items. It would
have been more appropriate to ask the respondents to
rephrase each item. Furthermore it would have been
easier to detect any discrepancies in the instrument if
the respondents were interviewed in face-to-face meet-
ings, rather than through mail and email. Additionally
decisions for when understanding was achieved for all
items were left to the subjective judgement of the
researchers. This introduced bias into the cross-cultural
adaptation process and may be one of the reasons why
the original scale failed.
Alternatively, it may be that the failure of an original
scale in a new setting is due to changes in society over
time [2]. The original scale was developed in the 1990s.
Since then several studies have found that abstinence-
oriented treatment in OMT is less effective than long-
term maintenance [33,34]. Based upon previous research
it may be that the debate has moved on to other issues.
Table 4 Confirmatory analysis of the new two-factor attitudinal scale
Single group analysis RMSEA (90% CI) CFI TLI AVE AIC BCC
OMT (n=126) F1 F2
Unadjusted model 0.072 (0.047; 0.096) 0.928 0.913 0.515 0.276 N/A N/A
Adjusted* 0.063 (0.034; 0.088) 0.946 0.934 0.509 0.276 N/A N/A
Harm reduction (n=108)
Unadjusted model 0.079 (0.052; 0.105) 0.905 0.884 0.506 0.267 N/A N/A
Adjusted model II** 0.049 (0.000; 0.080) 0.964 0.955 0.492 0.261 N/A N/A
Measurement Invariance
Adjusted model***
Equal form
(Unconstrained model)
0.039 (0.021; 0.053) 0.959 0.947 N/A N/A 284.528 301.136
Equal factor loading 0.043 (0.028; 0.056) 0.945 0.935 N/A N/A 288.024 301.587
Equal structural covariances 0.045 (0.031; 0.058) 0.937 0.928 N/A N/A 292.944 305.677
Equal measurement residuals 0.061 (0.050; 0.072) 0.874 0.868 N/A N/A 345.446 354.580
Saturated model N/A N/A N/A N/A N/A 364.000 414.377
Independent model 0.169 (0.160; 0.178) N/A N/A N/A N/A 1241.206 N/A
*Allowing covariance between Err1 ↔ Err6, ** Allowing covariance between Err 6 ↔ 7, Err 11 ↔ 12
***Allowing covariance between Err1 ↔ Err6, Err6 ↔ Err7, Err 11 ↔ 12
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Two unpublished studies support this hypothesis. The
original scale failed confirmatory analysis in Spain in
2000 and in NSW, Australia in 2003 (Caplehorn 2007,
personal communication). These findings suggest that
the failure of the original abstinence-oriented scale is
possibly related to changes over time.
In the cross-cultural adaptation process new items
were added to the instrument. It is possible that this
altered the structure of the original scale and thus the
scale failed confirmatory analysis. However, these items
were added at the end of the instrument, after the origi-
nal items. This means that the structure of the instru-
ment was the same as in the original. The additional
items enabled the researchers to find two new attitudi-
nal scales that were valid in the Norwegian setting. Yet
the need for additional items suggested that the original
instrument was not directly applicable in the new
setting.
Another difficulty in the described cross-cultural adapta-
tion process was to locate a second native English-speak-
ing back-translator. This was mainly due to financial
constraints. Instead for practical reasons, someone who
spoke and wrote English fluently was used as a second
back-translator. This illustrates that a thorough cross-cul-
tural adaption process may be difficult to achieve if there
are time or financial constraints. Regardless, the subse-
quent stages after the back-translation presumably
detected any discrepancies that might have occurred in
the back-translation process. However, it is important to
acknowledge that it may have been more appropriate to
use someone whose mother tongue was English.
Harm reduction staff were included in this study as a
comparison group to OMT staff. It was expected that
harm reduction staff would differ greatly from OMT
staff. This study confirmed that harm reduction staff dif-
fered from OMT staff in age, level of education and
experience in the addiction field. They had a lower
response rate which was possibly related to the data col-
lection procedure. The researcher was present in all
except one OMT centre while respondents completed
the questionnaires. In comparison the researcher was
only present in seven out of 12 ham reduction facilities
during data collection. Potentially it was easier for staff to
complete the questionnaire when the researcher was pre-
sent. Furthermore there were differences between groups
in knowledge and attitudinal scores. Importantly multi-
group analysis confirmed differences between the groups
in all parameters within the new attitudinal scale.
One of these parameters was the correlations between
the factors in the new attitudinal scale. There was a
higher correlation between the attitudinal factors in the
OMT group compared to harm reduction. The differ-
ences in correlations suggest that the two factors were
more predictive of each other among OMT staff
compared to harm reduction staff. If OMT staff believed
that no drug use should be tolerated, there was a high
possibility they believed the OMT programme should be
only for a selected few. Conversely, harm reduction staff
who believed drug use should not be tolerated among
OMT patients did not necessarily support an OMT pro-
gramme with limited access. Harm reduction staff were
sampled from various institutions and therefore work
within different ideologies and traditions. This could
explain why there was a lower correlation between the
factors among harm reduction staff.
The attitudes of OMT staff are of importance as they
are likely to influence treatment practices and, subse-
quently, treatment outcomes [8,10]. The persistent treat-
ment differences between the Norwegian OMT centres
documented through annual assessments [35,36], the
high correlations between the two factors within the
new attitudinal scale and high mean factor scores sup-
port the proposition that attitudes contribute to differ-
ences in treatment practices. This needs to be further
investigated in a parallel study of staff attitudes and
treatment outcomes.
Conclusions
The failure of the original scale highlights the impor-
tance of adapting instruments to current research set-
tings. It also emphasizes the importance of ensuring
that concepts within an instrument are equal between
the original and target language, time and context. If the
described stages in the cross-cultural adaptation process
had been omitted, the findings would have been mis-
leading, even if presented with apparent precision. Con-
sequently, it is important to consider possible barriers
when making a direct comparison between different
nations, cultures and times. There will always be some
differences between time-periods and settings, and in
many cases, cross-cultural adaptation is recommended
even for well established questionnaires.
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Research articleStaff attitudes and the associations with treatment 
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Abstract
Background: In opioid maintenance treatment (OMT) there are documented treatment differences both between 
countries and between OMT programmes. Some of these differences have been associated with staff attitudes. The 
aim of this study was to 1) assess if there were differences in staff attitudes within a national OMT programme, and 2) 
investigate the associations of staff attitudes with treatment organisation, clinical practices and outcomes.
Methods: This study was a cross-sectional multicentre study. Norwegian OMT staff (n = 140) were invited to participate 
in this study in 2007 using an instrument measuring attitudes towards OMT. The OMT programme comprised 14 
regional centres. Data describing treatment organisation, clinical practices and patient outcomes in these centres were 
extracted from the annual OMT programme assessment 2007. Centres were divided into three groups based upon 
mean attitudinal scores and labelled; "rehabilitation-oriented", "harm reduction-oriented" and "intermediate" centres.
Results: All invited staff (n = 140) participated. Staff attitudes differed between the centres. "Rehabilitation-oriented" 
centres had smaller caseloads, more frequent urine drug screening and increased case management (interdisciplinary 
meetings). In addition these centres had less drug use and more social rehabilitation among their patients in terms of 
long-term living arrangements, unemployment, and social security benefits as main income. "Intermediate" centres 
had the lowest treatment termination rate.
Conclusions: This study identified marked variations in staff attitudes between the regional centres within a national 
OMT programme. These variations were associated with measurable differences in caseload, intensity of case 
management and patient outcomes.
Background
Opioid maintenance treatment (OMT) is recognised as
an effective treatment in opiate dependence [1-3]. How-
ever OMT is a contentious issue and there are many
views on how to organise this treatment [4,5]. OMT pro-
grammes differ in treatment objectives, organisation and
clinical practices [6,7]. Treatment objectives range from
harm reduction [8], long-term maintenance and rehabili-
tation [2], to abstinence from all drugs including treat-
ment medication [9]. Diversity in treatment is evident
between countries [10], within countries [11], and even
between counsellors within the same treatment pro-
gramme [12]. Such differences have been associated with
variations in programme policies and staff attitudes [13-
15].
Several studies have assessed staff attitudes in the
addiction field [16-19]. Differences in staff attitudes have
been associated with treatment practices and outcomes
[20-22]. OMT staff 's favour towards abstinence-models
has been associated with provision of low dose metha-
done [22,23]. Abstinence-oriented OMT staff have had
more in-treatment drug use and more drop out com-
pared to programmes where staff were long-term mainte-
nance-oriented [20,21,24]. Strong attitudes and the
beliefs of the majority are more likely to influence behav-
iour than weaker attitudes held by only one or few per-
sons [25-28]. Consequently staff attitudes should be
included when OMT programmes are assessed.
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1 SERAF- Norwegian Centre for Addiction Research, Institute of Clinical 
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There are between 8 200 and 12 000 injecting drug
users in Norway [29] and approximately 5000 are cur-
rently in OMT [30]. In Norway OMT is only available
through a single publicly funded programme [31]. The
programme was established in 1998 and it has had a rapid
expansion from the initial intake of 240 patients to 4542
patients in 2007 [30]. The programme comprises 14
regional centres that are subject to the same treatment
standards specified in government guidelines [31].
Annual assessments of the OMT programme indicate
marked differences in treatment organisation, practices
and outcomes between centres [32,33]. This is of concern
since not all centres appear to achieve outcomes in line
with specified programme aims; reduced drug use and
improved social rehabilitation. Also OMT in Norway
relies on long-term three-party collaboration between an
OMT centre, a GP and social services, thus patients are
not entirely free to choose their treatment centre due to
logistical and geographical challenges. This means that
patients are required to accept their local centre's treat-
ment standards and practices. Thus it is important to
investigate factors that may be associated with differences
in treatment delivery and outcomes. The aim of this study
was to 1) assess if there were differences in staff attitudes
between OMT centres, and 2) investigate the associations
of staff attitudes with treatment organisation, clinical
practices and outcomes.
Methods
Setting
All clinical OMT staff (n = 140) in full-time and part-time
positions, in the national OMT programme in Norway
were invited to participate in this study. A list of all clini-
cal staff at each centre ensured that all staff were invited.
The national OMT programme comprised of fourteen
centres, and had from three to thirty-three staff
employed. In this study two of the fourteen centres were
merged because they had a joint staff group at the time of
the study.
Design
The study was a cross-sectional multicentre study. Data
was collected from August to November 2007, through
visits by the first author. The visits were in conjunction
with staff meetings when most staff were present. Staff
that were absent returned the questionnaire by mail. The
first author was present during the completion of the
questionnaires in all except one OMT centre. In the latter
OMT centre the researcher gave information during a
staff meeting and thereafter questionnaires were
returned by mail. Prepaid and anonymous envelopes
addressed to the researcher were attached to each ques-
tionnaire. Responders could choose not to respond to the
survey by returning an incomplete questionnaire in the
envelope. No names were collected, but number of staff
that had completed the questionnaire at each facility was
recorded. Centre managers were followed up to encour-
age that all staff returned questionnaires.
The study was approved by the Norwegian Regional
Ethics Committee and the Data Inspectorate May-June
2007. Participants received written and oral information
about the study. Respondents consented to participate in
the study by submitting the questionnaire. The question-
naire was semi-anonymous. This means that the name of
the facility and other demographic variables made some
staff theoretically identifiable. Participants were prom-
ised full anonymity. Demographic variables that identify
respondents will therefore be deleted upon completion of
the project.
Study instrument
The study instrument included a 13-item attitudinal scale
(Table 1). This scale was developed through exploratory
factor analysis and confirmed in structural equation
modelling using maximum likelihood analysis [34]. The
scale comprised two factors; "compliance" and "accessi-
bility" that were highly correlated in this OMT sample (r
= 0.71) [34]. The "Compliance"-items measured attitudes
towards in-treatment drug use in OMT and the "accessi-
bility"-items measured attitudes towards who should
have access to an OMT programme. The development of
the scale is described in details elsewhere [34]. Partici-
pants were asked to rate their responses to each item on a
five-point Likert scale from strongly disagree = 1 to
strongly agree = 5. Total scores were divided by number
of questions answered [35]. The theoretical range of
mean scores was 1.00 to 5.00.
Demographic variables such as treatment centre, age,
gender, profession, time employed in the organisation
and time worked in the addiction field were collected.
Labelling
In this study it was decided to label those with the lowest
mean scores on the attitudinal scale "harm reduction-ori-
ented" and those with the highest mean scores "rehabili-
tation-oriented". These labels were based upon the
content of the attitudinal scale. This means that the
"harm reduction-oriented" would be more likely to dis-
agree that drug use was a reason for disciplinary dis-
charge, more likely to agree that an OMT programme
should be available to all opiate dependents and more
likely to agree that GPs should be able to treat OMT
patients independently of the OMT programme. "Reha-
bilitation-oriented" would have opposite attitudes.
Division of centres into attitudinal groups
Each centre's mean attitudinal score was assessed. Cen-
tres were divided into three groups based upon these
scores, with equal number of centres in each group (4-5-
Gjersing et al. BMC Health Services Research 2010, 10:194
http://www.biomedcentral.com/1472-6963/10/194
Page 3 of 8
4). The four centres with the lowest scores were termed
"harm reduction-oriented" and the four centres with the
highest scores were termed "rehabilitation-oriented". The
five centres that had attitudinal scores between the two
opposing groups were termed "intermediate" centres.
OMT centre characteristics
The Norwegian OMT programme is assessed annually as
part of an ongoing quality assessment. A 53-item ques-
tionnaire is to be completed for each OMT patient. The
questionnaire comprises items such as main income,
employment status and drug use previous four weeks.
The questionnaire is completed by the patients' case
manager. The questionnaire was reliability tested in 2005
[36] and revised according to findings. Data was collected
as a multicentre study; however only aggregated informa-
tion was available for analysis. This study used data col-
lected in the third quarter of 2007.
Treatment variables and treatment outcomes
Patient/staff ratio, methadone and buprenorphine dose,
and interdisciplinary meeting attendance among patients
as well as supervised dispensing and urine drug screening
at each OMT centre were selected as treatment variables.
Drug use and social functioning variables were outcome
variables. Drug use variables were opioid, benzodiaz-
epines, central stimulants and cannabis use previous four
weeks. These data were measured by urine testing and
self-report. Social functioning was measured using cur-
rent employment status, social security benefits as main
income and type of living arrangements. Patient retention
was measured indirectly using the treatment termination
rate. This rate was calculated by adding all patients at the
beginning of the year to all new patients throughout the
year (n1). Thereafter this (n1) was subtracted from the
total number of patients at the end of the year (n2). Finally
this (n1-n2) was divided by the sum of all patients at the
beginning of the year and all new patients throughout the
year (n1).
Data analysis
Descriptive statistics and regression analysis were com-
pleted using SPSS version 16.0 [37]. A missing value pat-
Table 1: The 13-item scale measuring attitudes towards opioid maintenance treatment*
1 OMT patients who ignore repeated warnings to stop using heroin should be gradually withdrawn off methadone
2 OMT patients who continue to abuse non-opioid drugs (e.g. benzodiazepines) should have their dose of OMT medication reduced.
3 If repeated warnings of non-prescriptive use of benzodiazepines are ignored, the patient should be discharged from the OMT 
programme
4 If repeated warnings of use of Cannabis are ignored, the patient should be discharged from treatment (OMT)
5 The GP should waive the right to prescribe class A and B drugs other than the OMT medication to OMT patients
6 OMT patients who continue to take drugs and function poorly should be discharged from the OMT programme
7 It is unethical to discharge patients from the OMT programme due to continuing drug use and poor functioning**
8 OMT services should be expanded so all heroin addicts who want OMT can receive it**
9 It is unethical to deny heroin addicts OMT**
10 OMT's main aim is to reduce harmful effects of opioids and IV drug use (syringes)**
11 GPs should be able to initiate OMT on their own initiative**
12 Too many OMT-patients are discharged from the OMT programme**
13 Young opioid dependents (< 20) should not be offered OMT
*Participants were asked to rate their responses to each item on a five-point Likert scale from strongly disagree = 1 to strongly agree = 5.
** Reversed scores
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tern was generated for all items. Staff attitudes were
investigated by linear regression analysis with mean atti-
tudinal score as dependent variable and age, gender, staff
category, years of education, time worked in the addic-
tion field and OMT centre as independent or predictor
variables. Prevalence estimates were reported [38]. Dif-
ferences between centres were calculated using preva-
lence difference and 95% CI. Data on centre
characteristics were only available as aggregated informa-
tion (number of patients for each variable and total num-
ber of patients) for each regional centre (14 centres) was
available for analysis. Only completed items, from the
annual OMT assessment, were included in the analysis.
Not all items in each patient questionnaire were com-
pleted, thus the total number of respondents for each
item varied from the total number of patients at each cen-
tre.
Results
Respondents
All invited staff (n = 140) responded. One questionnaire
(1%) was discarded due to incomplete answers. Two
questionnaires had two missing responses and five ques-
tionnaires had one missing response, all items were com-
pleted in the remaining questionnaires. There were no
observed differences in age, gender, occupation and
length of employment in the addiction field between
OMT centres. 63% of staff were women. 59% of staff were
either social workers or registered nurses, and 21% were
psychologists and doctors. Other staff categories were
teachers and social educators. The majority of staff (60%)
were between forty and fifty-nine years old. No staff were
below twenty-five years. 62% had worked in the addiction
field more than six years.
OMT centres and staff attitudes
OMT centre was the only independent variable that was
associated with staff attitudes (r = 0.44, b = 0.06 95% CI
0.04; 0.08). No other personal descriptors contributed to
explaining variations in staff attitudes. An assessment of
each OMT centre found that mean attitudinal scores var-
ied from 2.50 (95% CI 2.01; 2.99) to 4.26 (95% 4.02; 4.51).
Treatment practices and staff attitudes
There were 4542 patients in the OMT programme by the
end of 2007. The four centres with the lowest attitudinal
scores ("harm reduction-oriented") comprised 1980
patients. The four centres with the highest attitudinal
scores ("rehabilitation-oriented") comprised 1049
patients (Table 2). Centres between the two opposing
groups in attitudinal scores ("intermediate") comprised
1513 patients. The patient/staff ratio varied between
groups. The "harm reduction-oriented" centres had a
much higher patient/staff ratio (30% (95% CI 27%; 34%, p
> 0.001) than the "rehabilitation-oriented" centres (Table
2).
All three groups had a high dose policy. The median
methadone dose varied from 106-111 mg and buprenor-
phine from 17-20 mg between groups (Table 2). Number
of supervised dispensing per patient per week, i.e. the use
of "take-home doses" did not differ greatly between
groups. However "harm reduction-oriented" centres were
12% (95% CI 5%; 18%, p > 0.001) less likely to collect
weekly urine specimens than the "rehabilitation-ori-
ented". In addition there were differences in number of
patients attending interdisciplinary meetings. 13% less
patients (95% CI 8%; 19%, p > 0.001) attended interdisci-
plinary meetings the previous four weeks in the "harm
reduction-oriented" centres compared to the "rehabilita-
tion-oriented".
The "intermediate" centres had rates in treatment char-
acteristics and practices between the "harm reduction-
oriented" and "rehabilitation-oriented" in most variables
(Table 2).
Treatment outcomes and staff attitudes
"Harm reduction-oriented" centres had more in-treat-
ment drug use compared to the two other groups (Table
3). More than half of the patients (55%) had used benzo-
diazepines previous four weeks compared to 32% in
"rehabilitation-oriented" centres. Furthermore "harm
reduction-oriented" centres had less social functioning
among their patients compared to the "rehabilitation-ori-
ented" centres; 17% more patients were unemployed, 12%
more patients had social security benefits as main income
and 15% less patients had long-term living arrangements
(Table 3). The "intermediate" centres were between the
"harm reduction-oriented" and "rehabilitation-oriented"
centres in all treatment outcomes. The exception was the
treatment termination rate, where the "intermediate" cen-
tres had the lowest rate.
Discussion
Within one national OMT programme there were differ-
ences between the regional centres in staff attitudes and
these differences were associated with variations in treat-
ment organisation, clinical practices and outcomes. Staff
in "rehabilitation-oriented" centres were more likely to
agree that drug use was a reason for disciplinary dis-
charge, disagree that an OMT programme should be
available to all opiate dependents and less likely to agree
that GPs should be able to treat OMT patients indepen-
dently of the national OMT programme. "Rehabilitation-
oriented" centres had smaller caseloads, more frequent
urine drug screening and increased case management
(interdisciplinary meetings). In addition these centres
had less drug use and more social rehabilitation among
their patients in terms of long-term living arrangements,
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unemployment, and social security benefits as main
income. "Intermediate" centres had the lowest treatment
termination rate.
Treatment approach has been associated with staff atti-
tudes [13]. Abstinence-oriented staff have provided lower
methadone doses compared to long-term maintenance
oriented staff [20-22]. Staff in pharmacies with negative
attitudes towards drug users have been less likely to pro-
vide needle exchange services [39]. Psychiatric staff with
positive attitudes towards seclusion of patients have been
more likely to be involved in this treatment practice [40].
In the current study centres with "rehabilitation-oriented"
staff urine drug screened more frequently and had
increased case management (interdisciplinary meeting
attendance) of their patients.
"Harm reduction-oriented" centres had almost double
caseload compared to the "rehabilitation-oriented" cen-
tres. Staff in these centres were more likely to agree that
OMT programmes should be open to all opiate depen-
dents and possibly attempted to admit all those who pre-
sented for treatment. Conversely it is possible that staff in
"rehabilitation-oriented" centres emphasised provision of
services and limited their intake to ensure a manageable
caseload.
Caseload affects services provided [41,42]. Smaller
caseloads allow staff more time per patient and this affect
the services provided [41-43]. However small caseloads
are not sufficient to ensure beneficial treatment out-
comes; quality of services, such as case management, are
also important [2]. Several studies have demonstrated
that increased case management are associated with less
drug use and increased social rehabilitation [44,45]. The
"rehabilitation-oriented" centres had smaller caseloads
and more intense case management of their patients.
This is possibly one of the reasons why they had less drug
use and more social rehabilitation among their patients
compared to the "harm reduction-oriented" centres.
Staff disapproval of in-treatment drug use could be
another reason why "rehabilitation-oriented" centres had
less drug use and more social rehabilitation among their
patients. High expectations of functioning have been
found to enhance patients' engagement in treatment ser-
vices and subsequently treatment outcomes [43]. Staff in
"rehabilitation-oriented" centres were more likely to
agree that in-treatment drug use was a reason for dis-
charge from treatment. It is possible that patients were
motivated to abstain from drug use because staff disap-
proved of in-treatment drug use, and thus staff attitudes
influenced patient's outcomes positively.
It is also possible that the "rehabilitation-oriented" cen-
tres only included patients that were less severely affected
and with a higher level of social functioning. A differen-
tial selection of patients into treatment would possibly
influence level of drug use and social functioning of
patients in treatment. Baseline information on each
patient was not available. However there was no differ-
ence between centres in patients' age and gender distribu-
tion. In addition the government regulations of the OMT
programme specify that only those with long-term opioid
dependence should be accepted into treatment. It is
Table 2: Treatment characteristics and practices for OMT centres when divided into attitudinal groups
Characteristics for each group "Harm reduction-oriented" 
centres
"Intermediate" 
centres
"Rehabilitation-oriented" 
centres
Total number of patients per group 1980 1513 1049
Patient/staff ratio 64 50 34
Methadone dose (mg)* 111 mg 111 mg 106 mg
Buprenorphine dose (mg)* 18 mg 17 mg 20 mg
Number of supervised dispensing per patient per week* 4.1 3.9 3.7
Number of patients urine drug screened at least once a week *† 62% (1419) 73% (1325) 74% (1115)
Interdisciplinary meeting previous 4 weeks*† 46% (1493) 49% (1326) 59% (1070)
*Median
† Number of patients in brackets
†† Not all items in each patient questionnaire were completed, thus the total number of respondents for each item varied from the total number 
of patients at each centre.
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therefore unlikely that the patients' characteristics alone
i.e. severity of dependence and drug use patterns, could
explain all the observed variations in social rehabilitation
and drug use.
Drug use is an important measure in OMT. Especially
benzodiazepine use has been related to increased risk of
overdose, other drug use, sharing injecting equipment,
and more psychopathology and social dysfunction [46-
48]. The "rehabilitation-oriented" centres had less drug
use and higher rates of social rehabilitation among their
patients.
Retention in treatment is another important treatment
indicator as OMT protect patients against increased risk
of mortality [49]. All centres had low treatment termina-
tion rates, but the "intermediate" centres had the lowest.
It may be that too strong attitudes ("harm reduction-ori-
ented" or "rehabilitation-oriented") in either directions
influence termination rates in OMT negatively.
Overall the cross-sectional design prevented any infer-
ence as to causality. Differences in treatment outcomes
were not necessarily caused by differences in either staff
attitudes or centre policies. Aggregated information pre-
vented detailed analysis based upon individual patients.
In addition the disciplinary discharge of patients for con-
tinuing drug use would reduce the proportion of patients
using drugs while in treatment. There were no systematic
patterns between response rate and treatment practices
and outcomes, which suggested that selection bias was
not a major concern.
Despite these limitations, the present study provides a
detailed description of the Norwegian OMT programme
and differences in staff attitudes, centres and patient out-
comes. This study was able to identify significant differ-
ences in staff attitudes, treatment practices and outcomes
between OMT centres. Furthermore all eligible staff par-
ticipated in this study which support the validity of the
Table 3: Treatment outcomes for OMT centres when divided into attitudinal groups
Treatment outcomes for 
each group
"Harm reduction-oriented" 
centres
"Intermediate" 
centres
"Rehabilitation-oriented" 
centres
Prevalence 
difference* (95% CI)
p-value**
Opioids use previous 
4 week
18% (1260)†† 15% (1215) 14% (1092) 4% (1%; 7%) 0.022
Central stimulant drug use 
previous 4 week
19% (1227) 19% (1200) 16% (1093) 3% (-1%; 6%) 0.102
Benzodiazepine use 
previous 4 weeks
55% (1296) 50% (1229) 32% (1102) 23% (18%; 29%) < 0.001
Cannabis use previous 
4 weeks
46% (1258) 41% (1224) 21% (1090) 25% (20%; 29%) < 0.001
Unemployed in treatment 83% (1503) 77% (1342) 66% (1112) 17% (10%; 23%) < 0.001
Social security benefits as 
main income
24% (1494) 15% (1257) 12% (1111) 12% (9%; 15%) < 0.001
Long-term living 
arrangements for patients 
in treatment
71% (1503) 82% (1344) 86% (1116) -15% (-21%; -8%) < 0.001
Treatment termination 
rate
11% (2213) 9%† (1667) 15% (1241) - 4% (-8%; - 2%) < 0.001
Total number of patients (n) per item in brackets
*Prevalence difference in percent. It was calculated by subtracting the prevalence of "harm reduction-oriented" centres from the prevalence of 
the "rehabilitation-oriented" centres.
**P-values estimated for prevalence difference
† Prevalence difference ("rehabilitation-oriented" vs. "intermediate" centres) 5% (4%; 9%), p-value < 0.001)
††Not all items in each patient questionnaire were completed, thus the total number of respondents for each item varied from the total number 
of patients at each centre.
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findings, as it was not only a selection of OMT staff that
responded.
Conclusions
This study identified marked variations in staff attitudes
between the regional centres within one national OMT
programme. These variations were associated with mea-
surable differences in caseload, intensity of case manage-
ment and patient outcomes. These findings add to the
body of evidence that staff attitudes are associated with
programme policies and the intensity and style of case
management and, subsequently, patient outcomes in opi-
oid maintenance treatment. Policy makers and stakehold-
ers, as well as programme managers and OMT staff need
to be aware of this.
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Appendix 2. The instrument used in the prison health staff study in NSW, Australia     
(study I) 
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Appendix 3. A suggested cross-cultural adaptation process  
 
 
Investigation of conceptual and item 
equivalence 
Literature review 
Discussion with experts in the field and 
members of target population 
Original instrument translated 
Translator I:  
Fluent in target language, good 
understanding of original language 
 Translator II:  
Fluent in target language, good 
understanding of original language 
A synthesized translated version 
Translator III: 
Fluent in target language, good 
understanding of original language 
Back-translations 
Back-translator I:  
Fluent in original language, good 
understanding of target language 
 Back-translator II:  
Fluent in original language, good 
understanding of target language 
A synthesized back-translated version 
Back-translator III: 
Fluent in original language, good 
understanding of target language 
Expert committee  
 
Instrument pretested 
 
Revised instrument  
Investigation of operational equivalence  
Literature review 
Discussions with experts in the field 
and members of target population 
Main study  
Exploratory and confirmatory analysis  
Final instrument  
Appendix 4. The instrument used in the Norwegian staff study (study II) 
 
Holdninger til og kunnskap om LAR 
Dette er en undersøkelse som skal måle holdninger til og kunnskap om LAR og arbeidet med rusavhengige. Det 
ene skjemaet er en blanding av kunnskaps- og holdningsutsagn og det andre skjemaet undersøker hvordan du 
oppfatter kunnskapsnivået ditt omkring rusfeltet. Mange utsagn har IKKE et entydig riktig eller galt 
svaralternativ. Svaralternativene er gradert fra ”svært uenig” til ”svært enig”. Om du kun er ”litt enig/uenig” i et 
utsagn krysser du av for svaralternativet ”enig/uenig”.  
 
Kryss av for det svaralternativet du tenker på først, dette er ikke et skjema som er ment å ta lang tid å fylle ut!  
 
Dato:        Arbeidssted:                    Kjønn : M   K                                                     
Alder:                                       ≤ 25 år  
    26-39    
     40-59   
     ≥ 60   
 
Hva er høyeste nivå på din utdanning? 
   3 årig høyskole/ Bachelor  
 Videreutdanning/   
  Spesialistutdanning    Spesifiser________________________________ 
Hovedfag/ Master   
  PhD      
  Postdoc     
  Annet      Spesifiser________________________________ 
 
Hvilken yrkesgruppe tilhører du? 
  Pedagog                                     
                    Vernepleier    
  Sykepleier         
  Sosionom       
                    Psykolog     
  Lege      
  Annet       Spesifiser________________________________ 
Hvor lenge har du arbeidet på din nåværende arbeidsplass? 
  0-2 år     
  3-5 år     
  6-10 år     
  11-15 år     
  ≥ 16 år                        
Hvilken stillingsprosent har du?            _______% 
Hvor lenge har du arbeidet innen fagområdet rus? 
  0-2 år       
                    3-5 år     
  6-10 år       
                    11-15 år     
  ≥ 16 år     
Utsagn Svært uenig Uenig Usikker Enig 
Svært 
enig 
1 LAR reduserer opiatavhengiges dødsrisiko            
     
2 Hvis de får mulighet, vil de fleste pasienter forbli i LAR livet ut   
     
     
3 LAR bør utvides slik at alle opiatavhengige som vil, kan få tilbudet 
     
     
4 Avholdenhet fra alle opioider (også metadon og buprenorfin) bør være hovedformålet med LAR 
     
     
5 Metadon er farligere for fosteret enn heroin      
     
6 LAR-pasienter som fortsetter å bruke heroin bør få dosen med LAR-medikamentet redusert      
7 Substitusjonsbehandling med metadon kan forårsake kronisk forstoppelse      
8 
Stabile metadondoser har en svært forstyrrende 
effekt på evnen til å kjøre bil eller å håndtere 
maskiner 
     
9 Substitusjonsbehandling med metadon kan føre til nedsatt sexlyst og menstruasjonsforstyrrelser      
10 LAR bør ikke tidsbegrenses      
11 Substitusjonsbehandling med metadon kan forårsake leverskader       
12 Substitusjonsbehandling med metadon forsterker en underliggende depresjon      
13 
Doseringen av LAR-medikamentet bør gradvis 
trappes ned så snart LAR-pasienten slutter å 
bruke heroin    
     
14 Det er uetisk å nekte opiatavhengige LAR      
15 Dersom gjentatte advarsler om bruk av heroin ignoreres, bør pasienten skrives ut av LAR      
16 Høy dose metadon reduserer (”blokkerer”) de  euforiske effektene ved injisert heroin      
17 LAR-pasienter bør kun få høy nok dose av LAR-medikamentet til å forebygge abstinenser      
18 Opiatavhengige i LAR reduserer sin kriminelle aktivitet             
        
 Utsagn Svært 
uenig Uenig Usikker Enig 
Svært 
enig 
19 LAR-pasienter bør oppmuntres til å bli i LAR i minst tre til fire år         
20 Det er uetisk å beholde en opiatavhengig i LAR på ubestemt tid             
21 Substitusjonsbehandling med metadon reduserer den opiatavhengiges heroinbruk         
22 
LAR-pasienter som fortsetter å bruke ikke-
opioider (f. eks benzodiazepiner) bør få dosen 
med LAR-medikamentet redusert 
     
23 Substitusjonsbehandling med metadon kan forårsake nyreskader      
24 
Behandlerens viktigste oppgave er å forberede 
den opiatavhengige til en medikamentfri 
tilværelse 
     
25 Konfrontasjon er nødvendig i behandlingen av rusavhengige      
26 
Dersom gjentatte advarsler om ikke forskrevet 
bruk av benzodiazepiner ignoreres, bør 
pasienten skrives ut av LAR 
     
27 LARs hovedformål er å redusere skadevirkningene av opiat- og sprøytebruk      
28 
Dersom gjentatte advarsler om bruk av 
cannabis ignoreres, bør pasienten skrives ut av 
LAR 
     
29 
Fastlegen bør frasi seg retten til å forskrive 
andre A- og B-preparater enn LAR-
medikamentet til LAR-pasienter 
     
30 Fastleger bør kunne starte opp pasienter med LAR-medikament på eget initiativ      
31 Altfor mange LAR-pasienter skrives ut av LAR-tiltakene      
32 LAR-pasienter er ikke til å stole på      
33 Noen LAR-pasienter burde aldri ha fått tilbud om LAR fordi de er for dårlig fungerende      
34 De fleste LAR-pasienter vil ruse seg hvis sjansen for å bli oppdaget er minimal      
35 LAR-pasienter med vedvarende rusing og dårlig fungering bør skrives ut av LAR      
36 Det er uetisk å skrive ut pasienter fra LAR på grunn av vedvarende rusing og dårlig fungering      
       
Original artikkel: Caplehorn JR, Irwig L, Saunders JB. Attitudes and beliefs of staff working in methadone maintenance clinics. 
Subst Use Misuse 1996 Mar;31(4):437-52. 
Oversatt med tillatelse fra Caplehorn  JR av Gjersing L, Clausen T, Aarhus Smeby N, Lightfoot C, Ulvedal L, Bjørkhaug I etter 
retningslinjer utarbeidet av: Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality-of-life 
measures: literature review and proposed guidelines. J Clin. Epidemiol 1993. vol. 46 pp. 1417-32. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Utsagn Svært uenig Uenig Usikker Enig 
Svært 
enig 
37 Substitusjonsmedikamentet beskytter bare mot heroinbruk, ikke mot bruk av andre rusmidler      
38 Tiltaket, der jeg jobber, gir det beste tilbudet av alle rustiltakene      
39 Unge opiatavhengige (< 20) bør ikke få tilbud om LAR      
Appendix 5. The new Norwegian attitudinal scale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Original items in italics 
“Compliance” items 
OMT patients who ignore repeated warnings to stop using heroin should be gradually 
withdrawn off methadone* 
OMT patients who continue to abuse non-opioid drugs (e.g. benzodiazepines) should have 
their dose of OMT medication reduced. 
If repeated warnings of non-prescriptive use of benzodiazepines are ignored, the patient 
should be discharged from the OMT program 
If repeated warnings of use of Cannabis are ignored, the patient should be discharged from 
treatment (OMT) 
The GP should waive the right to prescribe class A and B drugs other than the OMT 
medication to OMT patients 
OMT patients who continue to take drugs and function poorly should be discharged from the 
OMT program 
It is unethical to discharge patients from the OMT program due to continuing drug use and 
poor functioning 
“Accessibility” items 
OMT services should be expanded so all heroin addicts who want OMT can receive it 
It is unethical to deny heroin addicts OMT 
OMT's main aim is to reduce harmful effects of opioids and IV drug use (syringes) 
GPs should be able to initiate OMT-medication on their own initiative 
Too many LAR-patients are discharged from the OMT program 
Young opioid dependents (<20) should not be offered OMT 
Errata 
Page 24, paragraph 2, 8th row Removed ”s” in numbers 
Page 28, paragraph 2, 9th row added “-“ to needle exchange 
Page 53, paragraph 4, 1st row. Added comma after ”rehabilitation-oriented” and before 
comprised 
Page 62, paragraph 3, 5th row. Added an “a” before strength 
 
